{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:30:44Z","timestamp":1794886244065,"version":"4.9.1"},"reference-count":338,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Sulfonamide compounds, also known as sulfa drugs, are a significant class of\nsynthetic bacteriostatic antimicrobials and were the primary source of therapy against bacterial\ninfections before the introduction of penicillin in 1941. Hybridization of sulfonamides\nwith various pharmaceutically active heterocyclic moieties leads to sulfonamide\nhybrids with a wide variety of biological activities. Part B of this review presents the most\nrecent advances in designing and developing more two-component sulfonamide hybrids\ncontaining triazole, thiadiazole, triazine, oxazole\/ benzoxazole, isoxazole, oxadiazole, imidazole,\nbenzimidazole, furan, benzofuran, thiophene, pyrrole, indazole, tetrazole,\nchromene\/ chromone, pyridazine, quinoxaline, acridine, phthalazine, and xanthone between\n2015 and 2020. We hope this review helps the scientific community in designing\nmore useful sulfonamide hybrid drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867329666220722143547","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T06:58:06Z","timestamp":1658473086000},"page":"604-665","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recent Advances in Biological Active Sulfonamide based Hybrid\nCompounds Part B: Two-Component Sulfonamide Hybrids"],"prefix":"10.2174","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-0547","authenticated-orcid":true,"given":"Shakila","family":"Ghomashi","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-7298","authenticated-orcid":true,"given":"Reihane","family":"Ghomashi","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-2728","authenticated-orcid":true,"given":"Hamidreza","family":"Aghaei","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8843-3190","authenticated-orcid":true,"given":"Ahmad Reza","family":"Massah","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, Iran"},{"name":"Razi Chemistry\nResearch Center (RCRC), Shahreza Branch, Islamic Azad University, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3892\/or.2015.3876","volume":"33","author":"Tsukihara H.","year":"2015","unstructured":"Tsukihara H.; Nakagawa F.; Sakamoto K.; Ishida K.; Tanaka N.; Okabe H.; Uchida J.; Matsuo K.; Takechi T.; Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts. Oncol Rep 2015,33(5),2135-2142","journal-title":"Oncol Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.1021\/acs.jmedchem.5b00958","volume":"58","author":"Otto R.","year":"2015","unstructured":"Otto R.; Penzis R.; Gaube F.; Adolph O.; F&#xF6;hr K.J.; Warncke P.; Robaa D.; Appenroth D.; Fleck C.; Enzensperger C.; Lehmann J.; Winckler T.; Evaluation of homobivalent carbolines as designed multiple ligands for the treatment of neurodegenerative disorders. J Med Chem 2015,58(16),6710-6715","journal-title":"J Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ejmech.2014.10.062","volume":"94","author":"Dasari B.","year":"2015","unstructured":"Dasari B.; Jimmidi R.; Arya P.; Selected hybrid natural products as tubulin modulators. Eur J Med Chem 2015,94,497-508","journal-title":"Eur J Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bioorg.2015.10.001","volume":"63","author":"Kamath P.R.","year":"2015","unstructured":"Kamath P.R.; Sunil D.; Ajees A.A.; Pai K.S.; Das S.; Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies. Bioorg Chem 2015,63,101-109","journal-title":"Bioorg Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1574892810666151020101706","volume":"11","author":"Bordoloi D.","year":"2016","unstructured":"Bordoloi D.; Roy N.K.; Monisha J.; Padmavathi G.; Kunnumakkara A.B.; Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far. Recent Pat. Anti-Cancer Drug Discov 2016,11(1),67-97","journal-title":"Anti-Cancer Drug Discov"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.bmcl.2016.01.069","volume":"26","author":"Aldawsari F.S.","year":"2016","unstructured":"Aldawsari F.S.; Aguiar R.P.; Wiirzler L.A.M.; Aguayo-Ortiz R.; Aljuhani N.; Cuman R.K.N.; Medina-Franco J.L.; Siraki A.G.; Vel&#xE1;zquez-Mart&#xED;nez C.A.; Anti-inflammatory and antioxidant properties of a novel resveratrol-salicylate hybrid analog. Bioorg Med Chem Lett 2016,26(5),1411-1415","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejmech.2015.10.052","volume":"107","author":"Punganuru S.R.","year":"2016","unstructured":"Punganuru S.R.; Madala H.R.; Venugopal S.N.; Samala R.; Mikelis C.; Srivenugopal K.S.; Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties. Eur J Med Chem 2016,107,233-244","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","volume":"59","author":"Zha X.","year":"2016","unstructured":"Zha X.; Lamba D.; Zhang L.; Lou Y.; Xu C.; Kang D.; Chen L.; Xu Y.; Zhang L.; De Simone A.; Samez S.; Pesaresi A.; Stojan J.; Lopez M.G.; Egea J.; Andrisano V.; Bartolini M.; Novel tacrine\u2013benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer\u2019s disease: Design, synthesis, biological evaluation, and X-ray crystallography. J Med Chem 2016,59(1),114-131","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1021\/acs.orglett.5b03138","volume":"17","author":"Sugimoto K.","year":"2015","unstructured":"Sugimoto K.; Yajima H.; Hayashi Y.; Minato D.; Terasaki S.; Tohda C.; Matsuya Y.; Synthesis of denosomin\u2013vitamin D3 hybrids and evaluation of their anti-Alzheimer\u2019s disease activities. Org Lett 2015,17(23),5910-5913","journal-title":"Org Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11030-018-9902-8","volume":"23","author":"Shaabani A.","year":"2019","unstructured":"Shaabani A.; Nazeri M.T.; Afshari R.; 5-Amino-pyrazoles: Potent reagents in organic and medicinal synthesis. Mol Divers 2019,23(3),751-807","journal-title":"Mol Divers"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.bmc.2015.04.036","volume":"23","author":"Pingaew R.","year":"2015","unstructured":"Pingaew R.; Prachayasittikul V.; Mandi P.; Nantasenamat C.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V.; Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors. Bioorg Med Chem 2015,23(13),3472-3480","journal-title":"Bioorg Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"132132","DOI":"10.1016\/j.matlet.2022.132132","volume":"317","author":"Ghomashi R.","year":"2022","unstructured":"Ghomashi R.; Rabiei M.; Ghomashi S.; Massah A.R.; Kolahdoozan M.; Hosseinnezhad M.; Ebrahimi-Kahrizsangi R.; Palevicius A.; Nasiri S.; Janusas G.; Synthesis and investigation of the theoretical and experimental optical properties of some novel azo pyrazole sulfonamide hybrids. Mater Lett 2022,317,132132","journal-title":"Mater Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1007\/s11164-017-2870-2","volume":"43","author":"Maheswari C.S.","year":"2017","unstructured":"Maheswari C.S.; Ramesh R.; Lalitha A.; One-pot synthesis of symmetrical and unsymmetrical acridine sulfonamide derivatives catalyzed by p-TSA. Res Chem Intermed 2017,43(7),4165-4173","journal-title":"Res Chem Intermed"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157017806775789886","volume":"3","author":"Massah A.R.","year":"2006","unstructured":"Massah A.R.; Kazemi F.; Azadi D.; Farzaneh S.; Aliyan H.; Naghash H.J.; Momeni A.; A mild and chemoselective solvent-free method for the synthesis of N-aryl and N-alkylsulfonamides. Lett Org Chem 2006,3(3),235-241","journal-title":"Lett Org Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/znb-2015-0076","volume":"71","author":"Ebrahimi S.","year":"2016","unstructured":"Ebrahimi S.; Saiadi S.; Dakhilpour S.; Mirsattari S.N.; Massah A.R.; N-Acyl-N-(4-chlorophenyl)-4-nitrobenzene-] sulfonamides: Highly selective and efficient reagents for acylation of amines in water. Z Naturforsch B J Chem Sci 2016,71(2),95-104","journal-title":"Z Naturforsch B J Chem Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6792","DOI":"10.1021\/acs.jafc.9b07887","volume":"68","author":"Lin J.","year":"2020","unstructured":"Lin J.; Zhou S.; Xu J-X.; Yao W-Q.; Hao G-F.; Li Y-T.; Design, synthesis, and structure\u2013activity relationship of economical triazole sulfonamide aryl derivatives with high fungicidal activity. J Agric Food Chem 2020,68(25),6792-6801","journal-title":"J Agric Food Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","volume":"162","author":"Zhao C.","year":"2019","unstructured":"Zhao C.; Rakesh K.P.; Ravidar L.; Fang W-Y.; Qin H-L.; Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review. Eur J Med Chem 2019,162,679-734","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/1871520617666171103140749","volume":"18","author":"Rakesh K.P.","year":"2018","unstructured":"Rakesh K.P.; Wang S-M.; Leng J.; Ravindar L.; Asiri A.M.; Marwani H.M.; Qin H-L.; Recent development of sulfonyl or sulfonamide hybrids as potential anticancer agents: A key review. Anticancer Agents Med Chem 2018,18(4),488-505","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=19","first-page":"25","volume":"5","author":"Massah A.R.","year":"2019","unstructured":"Massah A.R.; Dakhilpour S.S.; Ebrahimi S.; Naseri S.; Nateghi M.; Mild and solvent-free synthesis and antibacterial evaluation of novel sulfonamides containing hydroxyl groups. Org Chem Res 2019,5(1),25-31","journal-title":"Org Chem Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejmech.2013.01.034","volume":"62","author":"Kamal A.","year":"2013","unstructured":"Kamal A.; Swapna P.; Shetti R.V.; Shaik A.B.; Narasimha Rao M.P.; Gupta S.; Synthesis, biological evaluation of new oxazolidino-sulfonamides as potential antimicrobial agents. Eur J Med Chem 2013,62,661-669","journal-title":"Eur J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"20088","DOI":"10.1038\/s41598-021-99618-w","volume":"11","author":"Esfahani S.N.","year":"2021","unstructured":"Esfahani S.N.; Damavandi M.S.; Sadeghi P.; Nazifi Z.; Salari-Jazi A.; Massah A.R.; Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation. Sci Rep 2021,11(1),20088","journal-title":"Sci Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.bmcl.2014.12.006","volume":"25","author":"Bag S.","year":"2015","unstructured":"Bag S.; Tulsan R.; Sood A.; Cho H.; Redjeb H.; Zhou W.; LeVine H.; T&#xF6;r&#xF6;k B.; T&#xF6;r&#xF6;k M.; Sulfonamides as multifunctional agents for Alzheimer\u2019s disease. Bioorg Med Chem Lett 2015,25(3),626-630","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.molstruc.2016.03.066","volume":"1117","author":"Abbas A.","year":"2016","unstructured":"Abbas A.; Murtaza S.; Tahir M.N.; Shamim S.; Sirajuddin M.; Rana U.A.; Naseem K.; Rafique H.; Synthesis, antioxidant, enzyme inhibition and DNA binding studies of novel N-benzylated derivatives of sulfonamide. J Mol Struct 2016,1117,269-275","journal-title":"J Mol Struct"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1016\/j.bmc.2013.05.043","volume":"21","author":"Ning X.","year":"2013","unstructured":"Ning X.; Guo Y.; Ma X.; Zhu R.; Tian C.; Zhang Z.; Wang X.; Ma Z.; Liu J.; Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury. Bioorg Med Chem 2013,21(17),5589-5597","journal-title":"Bioorg Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1016\/j.ejmech.2011.08.015","volume":"46","author":"Bano S.","year":"2011","unstructured":"Bano S.; Javed K.; Ahmad S.; Rathish I.G.; Singh S.; Alam M.S.; Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 2011,46(12),5763-5768","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1016\/j.bmcl.2013.06.072","volume":"23","author":"Ranjith P.K.","year":"2013","unstructured":"Ranjith P.K.; Rajeesh P.; Haridas K.R.; Susanta N.K.; Row T.N.G.; Rishikesan R.; Kumari N.S.; Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents. Bioorg Med Chem Lett 2013,23(18),5228-5234","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/j.tet.2014.03.038","volume":"70","author":"Ganguly A.K.","year":"2014","unstructured":"Ganguly A.K.; Alluri S.S.; Wang C-H.; Antropow A.; White A.; Caroccia D.; Biswas D.; Kang E.; Zhang L-K.; Carroll S.S.; Burlein C.; Fay J.; Orth P.; Strickland C.; Structural optimization of cyclic sulfonamide based novel HIV-1 protease inhibitors to picomolar affinities guided by X-ray crystallographic analysis. Tetrahedron 2014,70(18),2894-2904","journal-title":"Tetrahedron"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.bmcl.2019.06.008","volume":"29","author":"Follows B.","year":"2019","unstructured":"Follows B.; Fessler S.; Baumeister T.; Campbell A-M.; Zablocki M.M.; Li H.; Gotur D.; Wang Z.; Zheng X.; Molz L.; Nguyen C.; Herbertz T.; Wang L.; Bair K.; Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors. Bioorg Med Chem Lett 2019,29(16),2375-2382","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.1021\/acs.jmedchem.1c00690","volume":"64","author":"Li Y.","year":"2021","unstructured":"Li Y.; Fan W.; Gong Q.; Tian J.; Zhou M.; Li Q.; Uwituze L.B.; Zhang Z.; Hong R.; Wang R.; Structure-based optimization of 3-phenyl-N-(2-(3-phenylureido) ethyl)thiophene-2-sulfonamide derivatives as selective Mcl-1 Inhibitors. J Med Chem 2021,64(14),10260-10285","journal-title":"J Med Chem"},{"key":"ref=30","first-page":"565","volume":"16","author":"Pesaran Seiied Bonakdar A.","year":"2017","unstructured":"Pesaran Seiied Bonakdar A.; Vafaei F.; Farokhpour M.; Nasr Esfahani M.H.; Massah A.R.; Synthesis and anticancer activity assay of novel chalcone-sulfonamide derivatives. Iran J Pharm Res 2017,16(2),565-568","journal-title":"Iran J Pharm Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/med.10047","volume":"23","author":"Supuran C.T.","year":"2003","unstructured":"Supuran C.T.; Casini A.; Scozzafava A.; Protease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agents. Med Res Rev 2003,23(5),535-558","journal-title":"Med Res Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ejmech.2016.07.002","volume":"122","author":"Yang J.","year":"2016","unstructured":"Yang J.; Yang S.; Zhou S.; Lu D.; Ji L.; Li Z.; Yu S.; Meng X.; Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents. Eur J Med Chem 2016,122,488-496","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"103725","DOI":"10.1016\/j.bioorg.2020.103725","volume":"98","author":"Halawa A.H.","year":"2020","unstructured":"Halawa A.H.; Elgammal W.E.; Hassan S.M.; Hassan A.H.; Nassar H.S.; Ebrahim H.Y.; Mehany A.B.M.; El-Agrody A.M.; Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons. Bioorg Chem 2020,98,103725","journal-title":"Bioorg Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1016\/j.bmc.2018.09.001","volume":"26","author":"Chavez Alvarez A.C.","year":"2018","unstructured":"Chavez Alvarez A.C.; Zarifi Khosroshahi M.; C&#xF4;t&#xE9; M-F.; Gagn&#xE9;-Boulet M.; Fortin S.; 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells. Bioorg Med Chem 2018,26(18),5045-5052","journal-title":"Bioorg Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1016\/j.bmc.2013.05.042","volume":"21","author":"Vullo D.","year":"2013","unstructured":"Vullo D.; De Luca V.; Scozzafava A.; Carginale V.; Rossi M.; Supuran C.T.; Capasso C.; The extremo-&#x3B1;-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides. Bioorg Med Chem 2013,21(15),4521-4525","journal-title":"Bioorg Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/med.21713","volume":"40","author":"Mishra C.B.","year":"2020","unstructured":"Mishra C.B.; Tiwari M.; Supuran C.T.; Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med Res Rev 2020,40(6),2485-2565","journal-title":"Med Res Rev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1021\/acs.jmedchem.9b00282","volume":"62","author":"Mujumdar P.","year":"2019","unstructured":"Mujumdar P.; Kopecka J.; Bua S.; Supuran C.T.; Riganti C.; Poulsen S-A.; Carbonic anhydrase XII inhibitors overcome temozolomide resistance in glioblastoma. J Med Chem 2019,62(8),4174-4192","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","volume":"25","author":"Akocak S.","year":"2017","unstructured":"Akocak S.; Lolak N.; Nocentini A.; Karakoc G.; Tufan A.; Supuran C.T.; Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors. Bioorg Med Chem 2017,25(12),3093-3097","journal-title":"Bioorg Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bioorg.2017.11.015","volume":"76","author":"Ahmed M.","year":"2018","unstructured":"Ahmed M.; Qadir M.A.; Hameed A.; Arshad M.N.; Asiri A.M.; Muddassar M.; Sulfonamides containing curcumin scaffold: Synthesis, characterization, carbonic anhydrase inhibition and molecular docking studies. Bioorg Chem 2018,76,218-227","journal-title":"Bioorg Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0960-894X(02)00136-1","volume":"12","author":"Levin J.I.","year":"2002","unstructured":"Levin J.I.; Chen J.M.; Du M.T.; Nelson F.C.; Killar L.M.; Skala S.; Sung A.; Jin G.; Cowling R.; Barone D.; March C.J.; Mohler K.M.; Black R.A.; Skotnicki J.S.; Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1\u2032 group. Bioorg Med Chem Lett 2002,12(8),1199-1202","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1016\/S0968-0896(01)00200-0","volume":"9","author":"Kim D-K.","year":"2001","unstructured":"Kim D-K.; Lee J.Y.; Lee N.; Ryu D.H.; Kim J.S.; Lee S.; Choi J.Y.; Ryu J.H.; Kim N.H.; Im, G.J.; Choi, W.S.; Kim, T.K. Synthesis and phosphodiesterase inhibitory activity of new sildenafil analogues containing a carboxylic acid group in the 5\u2032-sulfonamide moiety of a phenyl ring. Bioorg Med Chem 2001,9(11),3013-3021","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1515\/jbcpp-2021-0349","volume":"33","author":"Ghasemnejad-Berenji M.","year":"2021","unstructured":"Ghasemnejad-Berenji M.; Can sulfasalazine as an old drug with immunomodulatory and anti-inflammatory effects be effective in COVID-19? J Basic Clin Physiol Pharmacol 2021,33(1),113-115","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","volume":"27","author":"Bozorov K.","year":"2019","unstructured":"Bozorov K.; Zhao J.; Aisa H.A.; 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg Med Chem 2019,27(16),3511-3531","journal-title":"Bioorg Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6393428","DOI":"10.1155\/2020\/6393428","volume":"2020","author":"Assali M.","year":"2020","unstructured":"Assali M.; Abualhasan M.; Sawaftah H.; Hawash M.; Mousa A.; Synthesis, biological activity, and molecular modeling studies of pyrazole and triazole derivatives as selective COX-2 inhibitors. J Chem 2020,2020,6393428","journal-title":"J Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s40064-015-1352-5","volume":"4","author":"Prachayasittikul V.","year":"2015","unstructured":"Prachayasittikul V.; Pingaew R.; Anuwongcharoen N.; Worachartcheewan A.; Nantasenamat C.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V.; Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modification. Springerplus 2015,4(1),571","journal-title":"Springerplus"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/slct.201800072","volume":"3","author":"Swaroop D.K.","year":"2018","unstructured":"Swaroop D.K.; Kumar N.R.; Ratnakarreddy K.; Raja G.; Srigiridhar K.; Poornachandra Y.; Kumar C.G.; Babu N.J.; Kumar G.S.; Narsaiah B.; Novel 1, 2, 3\u2010triazole\u2010functionalized 1, 2\u2010benzothiazine 1, 1\u2010dioxide derivatives: Regioselective synthesis, biological evaluation and docking studies. ChemistrySelect 2018,3(8),2398-2403","journal-title":"ChemistrySelect"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bioorg.2018.10.003","volume":"83","author":"da Silva V.D.","year":"2019","unstructured":"da Silva V.D.; de Faria B.M.; Colombo E.; Ascari L.; Freitas G.P.A.; Flores L.S.; Cordeiro Y.; Rom&#xE3;o L.; Buarque C.D.; Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells. Bioorg Chem 2019,83,87-97","journal-title":"Bioorg Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ejmech.2007.03.033","volume":"43","author":"Sztanke K.","year":"2008","unstructured":"Sztanke K.; Tuzimski T.; Rzymowska J.; Pasternak K.; Kandefer-Szersze\u0144 M.; Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives. Eur J Med Chem 2008,43(2),404-419","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/07391102.2019.1711193","volume":"39","author":"Khan B.","year":"2021","unstructured":"Khan B.; Naiyer A.; Athar F.; Ali S.; Thakur S.C.; Synthesis, characterization and anti-inflammatory activity evaluation of 1,2,4-triazole and its derivatives as a potential scaffold for the synthesis of drugs against prostaglandin-endoperoxide synthase. J Biomol Struct Dyn 2021,39(2),457-475","journal-title":"J Biomol Struct Dyn"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/jhet.3888","volume":"57","author":"Batra N.","year":"2020","unstructured":"Batra N.; Rajendran V.; Wadi I.; Lathwal A.; Dutta R.K.; Ghosh P.C.; Gupta R.D.; Nath M.; Synthesis, characterization, and antiplasmodial efficacy of sulfonamide\u2010appended [1, 2, 3]\u2010triazoles. J Heterocycl Chem 2020,57(4),1625-1636","journal-title":"J Heterocycl Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1080\/00397911.2020.1802758","volume":"50","author":"Kaushik C.","year":"2020","unstructured":"Kaushik C.; Chahal M.; Luxmi R.; Kumar D.; Kumar A.; Kumar M.; Singh D.; Synthesis, characterization and biological activities of sulfonamide tagged 1, 2, 3-triazoles. Synth Commun 2020,50(22),3443-3461","journal-title":"Synth Commun"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1080\/00397911.2017.1333124","volume":"47","author":"Kaushik C.","year":"2017","unstructured":"Kaushik C.; Pahwa A.; Kumar A.; Singh D.; Kumar K.; Facile synthesis, characterization, and antimicrobial studies of some disubstituted 1, 2, 3-triazoles with sulfonamide functionality. Synth Commun 2017,47(16),1485-1494","journal-title":"Synth Commun"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/molecules22091470","volume":"22","author":"Fu D-J.","year":"2017","unstructured":"Fu D-J.; Liu J-F.; Zhao R-H.; Li J-H.; Zhang S-Y.; Zhang Y-B.; Design and antiproliferative evaluation of novel sulfanilamide derivatives as potential tubulin polymerization inhibitors. Molecules 2017,22(9),1470","journal-title":"Molecules"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","volume":"59","author":"Nocentini A.","year":"2016","unstructured":"Nocentini A.; Ferraroni M.; Carta F.; Ceruso M.; Gratteri P.; Lanzi C.; Masini E.; Supuran C.T.; Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: Synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations. J Med Chem 2016,59(23),10692-10704","journal-title":"J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"115424","DOI":"10.1016\/j.bmc.2020.115424","volume":"28","author":"Aneja B.","year":"2020","unstructured":"Aneja B.; Queen A.; Khan P.; Shamsi F.; Hussain A.; Hasan P.; Rizvi M.M.A.; Daniliuc C.G.; Alajmi M.F.; Mohsin M.; Hassan M.I.; Abid M.; Design, synthesis","journal-title":"Bioorg Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bmcl.2016.12.030","volume":"27","author":"Mareddy J.","year":"2017","unstructured":"Mareddy J.; Suresh N.; Kumar C.G.; Kapavarapu R.; Jayasree A.; Pal S.; 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents. Bioorg Med Chem Lett 2017,27(3),518-523","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"115598","DOI":"10.1016\/j.bmc.2020.115598","volume":"28","author":"Muhammad Z.","year":"2020","unstructured":"Muhammad Z.; Skagseth S.; Boomgaren M.; Akhter S.; Fr&#xF6;hlich C.; Ismael A.; Christopeit T.; Bayer A.; Leiros H.S.; Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-&#x3B2;-lactamases. Bioorg Med Chem 2020,28(15),115598","journal-title":"Bioorg Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/14756366.2019.1629432","volume":"34","author":"Swain B.","year":"2019","unstructured":"Swain B.; Angeli A.; Angapelly S.; Thacker P.S.; Singh P.; Supuran C.T.; Arifuddin M.; Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors. J Enzyme Inhib Med Chem 2019,34(1),1199-1209","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/DDDT.S225201","volume":"14","author":"Jia Y.","year":"2020","unstructured":"Jia Y.; Li M.; Cao Y.; Feng W.; Li X.; Xue W.; Shi H.; Discovery of a novel benzenesulfonamide analogue that inhibits proliferation and metastasis against ovarian cancer OVCAR-8 cells. Drug Des Devel Ther 2020,14,207-216","journal-title":"Drug Des Devel Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/10426507.2016.1146273","volume":"191","author":"Reddy N.V.","year":"2016","unstructured":"Reddy N.V.; Narsimha S.; Sudhakar L.; Battula K.S.; Althaf Hussain S.N.; N\u2032-(hexane-1, 6-diyl) bis (N-((1-aryl\/alkyl-1H-1, 2, 3-triazol-4-yl) methyl)-4-methyl benzenesulfonamide): Synthesis, antibacterial, antioxidant, and DNA-cleavage activities. Phosphorus Sulfur Silicon Relat Elem 2016,191(8),1118-1122","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1039\/C8NJ04385J","volume":"43","author":"Puratchikody A.","year":"2019","unstructured":"Puratchikody A.; Umamaheswari A.; Irfan N.; Sinha S.; Manju S.; Ramanan M.; Ramamoorthy G.; Doble M.; A novel class of tyrosine derivatives as dual 5-LOX and COX-2\/mPGES1 inhibitors with PGE 2 mediated anticancer properties. New J Chem 2019,43(2),834-846","journal-title":"New J Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bioorg.2019.01.065","volume":"86","author":"Bua S.","year":"2019","unstructured":"Bua S.; Osman S.M.; Del Prete S.; Capasso C.; AlOthman Z.; Nocentini A.; Supuran C.T.; Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae. Bioorg Chem 2019,86,183-186","journal-title":"Bioorg Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1021\/acs.jmedchem.8b01403","volume":"62","author":"Brai A.","year":"2019","unstructured":"Brai A.; Martelli F.; Riva V.; Garbelli A.; Fazi R.; Zamperini C.; Pollutri A.; Falsitta L.; Ronzini S.; Maccari L.; Maga G.; Giannecchini S.; Botta M.; DDX3X helicase inhibitors as a new strategy to fight the West Nile virus infection. J Med Chem 2019,62(5),2333-2347","journal-title":"J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12039-017-1415-y","volume":"130","author":"Fu D-J.","year":"2018","unstructured":"Fu D-J.; Hou Y-H.; Zhang S-Y.; Zhang Y-B.; Efficient click reaction towards novel sulfonamide hybrids by molecular hybridization strategy as antiproliferative agents. J Chem Sci 2018,130(1),1-7","journal-title":"J Chem Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ejmech.2018.06.021","volume":"155","author":"Kumar R.","year":"2018","unstructured":"Kumar R.; Vats L.; Bua S.; Supuran C.T.; Sharma P.K.; Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors. Eur J Med Chem 2018,155,545-551","journal-title":"Eur J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/14756366.2017.1367775","volume":"32","author":"Kumar R.","year":"2017","unstructured":"Kumar R.; Sharma V.; Bua S.; Supuran C.T.; Sharma P.K.; Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity. J Enzyme Inhib Med Chem 2017,32(1),1187-1194","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejmech.2018.03.030","volume":"150","author":"Vats L.","year":"2018","unstructured":"Vats L.; Sharma V.; Angeli A.; Kumar R.; Supuran C.T.; Sharma P.K.; Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors. Eur J Med Chem 2018,150,678-686","journal-title":"Eur J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/ijms17081371","volume":"17","author":"Pala N.","year":"2016","unstructured":"Pala N.; Esposito F.; Rogolino D.; Carcelli M.; Sanna V.; Palomba M.; Naesens L.; Corona A.; Grandi N.; Tramontano E.; Sechi M.; Inhibitory effect of 2, 3, 5, 6-tetrafluoro-4-[4-(aryl)-1H-1, 2, 3-triazol-1-yl] benzenesulfonamide derivatives on HIV reverse transcriptase associated RNase H activities. Int J Mol Sci 2016,17(8),1371","journal-title":"Int J Mol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"111843","DOI":"10.1016\/j.ejmech.2019.111843","volume":"185","author":"Said M.A.","year":"2020","unstructured":"Said M.A.; Eldehna W.M.; Nocentini A.; Bonardi A.; Fahim S.H.; Bua S.; Soliman D.H.; Abdel-Aziz H.A.; Gratteri P.; Abou-Seri S.M.; Supuran C.T.; Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors. Eur J Med Chem 2020,185,111843","journal-title":"Eur J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"112114","DOI":"10.1016\/j.ejmech.2020.112114","volume":"190","author":"Liao L.","year":"2020","unstructured":"Liao L.; Jiang C.; Chen J.; Shi J.; Li X.; Wang Y.; Wen J.; Zhou S.; Liang J.; Lao Y.; Zhang J.; Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential neuroprotectant against ischemic brain injury. Eur J Med Chem 2020,190,112114","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"103878","DOI":"10.1016\/j.bioorg.2020.103878","volume":"100","author":"Ibrahim T.S.","year":"2020","unstructured":"Ibrahim T.S.; Salem I.M.; Mostafa S.M.; El-Sabbagh O.I.; ElKhamisi M.K.M.; Hegazy L.; Elgendy B.; Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold. Bioorg Chem 2020,100,103878","journal-title":"Bioorg Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/ph13090252","volume":"13","author":"Malebari A.M.","year":"2020","unstructured":"Malebari A.M.; Ibrahim T.S.; Salem I.M.; Salama I.; Khayyat A.N.; Mostafa S.M.; El-Sabbagh O.I.; Darwish K.M.; The anticancer activity for the bumetanide-based analogs via targeting the tumor-associated membrane-bound human carbonic anhydrase-IX enzyme. Pharmaceuticals (Basel) 2020,13(9),252","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/chir.22607","volume":"28","author":"Ba&#x15F;aran E.","year":"2016","unstructured":"Ba&#x15F;aran E.; Karak&#xFC;&#xE7;&#xFC;k-Iyido&#x11F;an A.; Schols D.; Oru&#xE7;-Emre E.E.; Synthesis of novel chiral sulfonamide-bearing 1,2,4-triazole-3-thione analogs derived from D- and L-phenylalanine esters as potential anti-influenza agents. Chirality 2016,28(6),495-513","journal-title":"Chirality"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1573406414666181106124852","volume":"16","author":"He S-C.","year":"2020","unstructured":"He S-C.; Zhang H-Z.; Zhang H-J.; Sun Q.; Zhou C-H.; Design and synthesis of novel sulfonamide-derived triazoles and bioactivity exploration. Med Chem 2020,16(1),104-118","journal-title":"Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"111698","DOI":"10.1016\/j.ejmech.2019.111698","volume":"183","author":"Vats L.","year":"2019","unstructured":"Vats L.; Kumar R.; Bua S.; Nocentini A.; Gratteri P.; Supuran C.T.; Sharma P.K.; Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors. Eur J Med Chem 2019,183,111698","journal-title":"Eur J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/13543776.2017.1272575","volume":"27","author":"Dawood K.M.","year":"2017","unstructured":"Dawood K.M.; Farghaly T.A.; Thiadiazole inhibitors: A patent review. Expert Opin Ther Pat 2017,27(4),477-505","journal-title":"Expert Opin Ther Pat"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cmdc.201200355","volume":"8","author":"Li Y.","year":"2013","unstructured":"Li Y.; Geng J.; Liu Y.; Yu S.; Zhao G.; Thiadiazole-a promising structure in medicinal chemistry. ChemMedChem 2013,8(1),27-41","journal-title":"ChemMedChem"},{"key":"ref=78","first-page":"528","volume":"1","author":"Bhuva H.","year":"2011","unstructured":"Bhuva H.; Sahu D.; Shah B.; Modi D.C.; Patel M.B.; Biological profile of thiadiazole. Pharmacologyonline 2011,1,528-543","journal-title":"Pharmacologyonline"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/jm061320h","volume":"50","author":"Wilkinson B.L.","year":"2007","unstructured":"Wilkinson B.L.; Bornaghi L.F.; Houston T.A.; Innocenti A.; Vullo D.; Supuran C.T.; Poulsen S-A.; Carbonic anhydrase inhibitors: Inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. J Med Chem 2007,50(7),1651-1657","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"9046","DOI":"10.3390\/molecules15129046","volume":"15","author":"Chen Z.","year":"2010","unstructured":"Chen Z.; Xu W.; Liu K.; Yang S.; Fan H.; Bhadury P.S.; Hu D.Y.; Zhang Y.; Synthesis and antiviral activity of 5 (4 chlorophenyl)-1,3,4-thiadiazole sulfonamides. Molecules 2010,15(12),9046-9056","journal-title":"Molecules"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1248\/cpb.58.160","volume":"58","author":"Camoutsis C.","year":"2010","unstructured":"Camoutsis C.; Geronikaki A.; Ciric A.; Sokovi\u0107 M.; Zoumpoulakis P.; Zervou M.; Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies. Chem Pharm Bull (Tokyo) 2010,58(2),160-167","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/cmdc.201900703","volume":"15","author":"Jiang C.","year":"2020","unstructured":"Jiang C.; Shi J.; Liao L.; Zhang L.; Liu J.; Wang Y.; Lao Y.; Zhang J.; 5-[2-(N-(Substituted phenyl)acetamide)]amino-1,3,4-thiadiazole-2-sulfonamides as selective Carbonic Anhydrase II Inhibitors with neuroprotective effects. ChemMedChem 2020,15(8),705-715","journal-title":"ChemMedChem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11030-018-9851-2","volume":"22","author":"Shafique M.","year":"2018","unstructured":"Shafique M.; Hameed S.; Naseer M.M.; Al-Masoudi N.A.; Synthesis of new chiral 1,3,4-thiadiazole-based di- and tri-arylsulfonamide residues and evaluation of in vitro anti-HIV activity and cytotoxicity. Mol Divers 2018,22(4),957-968","journal-title":"Mol Divers"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/14756366.2016.1197221","volume":"31","author":"Mishra C.B.","year":"2016","unstructured":"Mishra C.B.; Kumari S.; Angeli A.; Monti S.M.; Buonanno M.; Prakash A.; Tiwari M.; Supuran C.T.; Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl\/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphen-] ylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors. J Enzyme Inhib Med Chem 2016,31(Suppl. 2),174-179","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","volume":"87","author":"Abo-Ashour M.F.","year":"2019","unstructured":"Abo-Ashour M.F.; Eldehna W.M.; Nocentini A.; Ibrahim H.S.; Bua S.; Abdel-Aziz H.A.; Abou-Seri S.M.; Supuran C.T.; Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies. Bioorg Chem 2019,87,794-802","journal-title":"Bioorg Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/10426507.2018.1452924","volume":"193","author":"Karaku&#x15F; S.","year":"2018","unstructured":"Karaku&#x15F; S.; Tok F.; T&#xFC;rk S.; Salva E.; Tatar G.; Task\u0131n-Tok T.; Kocyigit-Kaymakc\u0131oglu B.; Synthesis, anticancer activity and ADMET studies of N-(5-methyl-1, 3, 4-thiadiazol-2-yl)-4-[(3-substituted) ureido\/thioureido] benzenesulfonamide derivatives. Phosphorus Sulfur Silicon Relat Elem 2018,193(8),528-534","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.bmc.2016.05.072","volume":"24","author":"Nocentini A.","year":"2016","unstructured":"Nocentini A.; Vullo D.; Bartolucci G.; Supuran C.T.; N-Nitrosulfonamides: A new chemotype for carbonic anhydrase inhibition. Bioorg Med Chem 2016,24(16),3612-3617","journal-title":"Bioorg Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"111804","DOI":"10.1016\/j.ejmech.2019.111804","volume":"185","author":"Liu H.","year":"2020","unstructured":"Liu H.; Long S.; Rakesh K.P.; Zha G-F.; Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents. Eur J Med Chem 2020,185,111804","journal-title":"Eur J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ejmech.2017.09.035","volume":"142","author":"Cascioferro S.","year":"2017","unstructured":"Cascioferro S.; Parrino B.; Span&#xF2; V.; Carbone A.; Montalbano A.; Barraja P.; Diana P.; Cirrincione G.; 1,3,5-Triazines: A promising scaffold for anticancer drugs development. Eur J Med Chem 2017,142,523-549","journal-title":"Eur J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1248\/cpb.c15-00309","volume":"63","author":"Mibu N.","year":"2015","unstructured":"Mibu N.; Yokomizo K.; Aki H.; Ota N.; Fujii H.; Yuzuriha A.; Saneyoshi S.; Tanaka A.; Koga A.; Zhou J.; Miyata T.; Sumoto K.; Synthesis and antiviral evaluation of some C3-symmetrical trialkoxy-substituted 1, 3, 5-triazines and their molecular geometry. Chem Pharm Bull (Tokyo) 2015,63(11),935-944","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.bmcl.2016.12.038","volume":"27","author":"Mull E.S.","year":"2017","unstructured":"Mull E.S.; Sun L-Q.; Zhao Q.; Eggers B.; Pokornowski K.; Zhai G.; Rajamani R.; Jenkins S.; Kramer M.; Wang Y-K.; Fang H.; Tenney D.; Baldick C.J.; Cockett M.I.; Meanwell N.A.; Scola P.M.; Functionalized triazines as potent HCV entry inhibitors. Bioorg Med Chem Lett 2017,27(4),1089-1093","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"128687","DOI":"10.1016\/j.molstruc.2020.128687","volume":"1220","author":"Patil V.","year":"2020","unstructured":"Patil V.; Noonikara-Poyil A.; Joshi S.D.; Patil S.A.; Patil S.A.; Lewis A.M.; Bugarin A.; Synthesis, molecular docking studies, and in vitro evaluation of 1,3,5-triazine derivatives as promising antimicrobial agents. J Mol Struct 2020,1220,128687","journal-title":"J Mol Struct"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejmech.2016.09.067","volume":"125","author":"Wang G.","year":"2017","unstructured":"Wang G.; Peng Z.; Wang J.; Li X.; Li J.; Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential &#x3B1;-glucosidase inhibitors. Eur J Med Chem 2017,125,423-429","journal-title":"Eur J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1016\/j.bmcl.2012.09.062","volume":"22","author":"Zhan P.","year":"2012","unstructured":"Zhan P.; Li X.; Li Z.; Chen X.; Tian Y.; Chen W.; Liu X.; Pannecouque C.; De Clercq E.; Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs. Bioorg Med Chem Lett 2012,22(23),7155-7162","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cclet.2016.12.037","volume":"28","author":"Arshad M.","year":"2017","unstructured":"Arshad M.; Bhat A.R.; Hoi K.K.; Choi I.; Athar F.; Synthesis, characterization and antibacterial screening of some novel 1,2,4-triazine derivatives. Chin Chem Lett 2017,28(7),1559-1565","journal-title":"Chin Chem Lett"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ejmech.2017.08.009","volume":"142","author":"Cascioferro S.","year":"2017","unstructured":"Cascioferro S.; Parrino B.; Span&#xF2; V.; Carbone A.; Montalbano A.; Barraja P.; Diana P.; Cirrincione G.; An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. Eur J Med Chem 2017,142,328-375","journal-title":"Eur J Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","volume":"15","author":"Garaj V.","year":"2005","unstructured":"Garaj V.; Puccetti L.; Fasolis G.; Winum J-Y.; Montero J-L.; Scozzafava A.; Vullo D.; Innocenti A.; Supuran C.T.; Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg Med Chem Lett 2005,15(12),3102-3108","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"22","DOI":"10.25135\/acg.bmcr.22.20.07.1706","volume":"3","author":"Lolak N.","year":"2020","unstructured":"Lolak N.; Tune&#x11F; M.; Do&#x11F;an A.; Bo&#x11F;a M.; Akocak S.; Synthesis and biological evaluation of 1, 3, 5-triazine-substituted ureido benzenesulfonamides as antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitors. Bioorg Med Chem Rep 2020,3(2),22-31","journal-title":"Bioorg Med Chem Rep"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/molecules25102324","volume":"25","author":"Branowska D.","year":"2020","unstructured":"Branowska D.; Karczmarzyk Z.; Woli\u0144ska E.; Wysocki W.; Morawiak M.; Urba\u0144czyk-Lipkowska Z.; Bielawska A.; Bielawski K.; 1, 2, 4-Triazine sulfonamides: Synthesis by sulfenamide intermediates, in vitro anticancer screening, structural characterization, and molecular docking study. Molecules 2020,25(10),2324","journal-title":"Molecules"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bioorg.2017.12.034","volume":"77","author":"Havr&#xE1;nkov&#xE1; E.","year":"2018","unstructured":"Havr&#xE1;nkov&#xE1; E.; Cs&#xF6;llei J.; Vullo D.; Garaj V.; Pazdera P.; Supuran C.T.; Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action. Bioorg Chem 2018,77,25-37","journal-title":"Bioorg Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bioorg.2018.08.005","volume":"81","author":"Miku\u0161 P.","year":"2018","unstructured":"Miku\u0161 P.; Kraj&#x10D;iov&#xE1; D.; Mikulov&#xE1; M.; Horv&#xE1;th B.; Pecher D.; Garaj V.; Bua S.; Angeli A.; Supuran C.T.; Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX. Bioorg Chem 2018,81,241-252","journal-title":"Bioorg Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.ejmech.2017.11.005","volume":"143","author":"&#x17B;o\u0142nowska B.","year":"2018","unstructured":"&#x17B;o\u0142nowska B.; S\u0142awi\u0144ski J.; Szafra\u0144ski K.; Angeli A.; Supuran C.T.; Kawiak A.; Wiecz&#xF3;r M.; Zieli\u0144ska J.; B\u0105czek T.; Bartoszewska S.; Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Eur J Med Chem 2018,143,1931-1941","journal-title":"Eur J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bioorg.2018.10.005","volume":"82","author":"Lolak N.","year":"2019","unstructured":"Lolak N.; Akocak S.; Bua S.; Supuran C.T.; Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors. Bioorg Chem 2019,82,117-122","journal-title":"Bioorg Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","volume":"27","author":"Lolak N.","year":"2019","unstructured":"Lolak N.; Akocak S.; Bua S.; Sanku R.K.K.; Supuran C.T.; Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors. Bioorg Med Chem 2019,27(8),1588-1594","journal-title":"Bioorg Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"103897","DOI":"10.1016\/j.bioorg.2020.103897","volume":"100","author":"Lolak N.","year":"2020","unstructured":"Lolak N.; Akocak S.; T&#xFC;rke&#x15F; C.; Taslimi P.; I&#x15F;\u0131k M.; Beydemir &#x15E;.; G&#xFC;l&#xE7;in \u0130.; Durgun M.; Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, &#x3B1;-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs. Bioorg Chem 2020,100,103897","journal-title":"Bioorg Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/14756366.2019.1707196","volume":"35","author":"Lolak N.","year":"2020","unstructured":"Lolak N.; Boga M.; Tuneg M.; Karakoc G.; Akocak S.; Supuran C.T.; Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile. J Enzyme Inhib Med Chem 2020,35(1),424-431","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.3390\/ijms21103661","volume":"21","author":"Mikulov&#xE1; M.B.","year":"2020","unstructured":"Mikulov&#xE1; M.B.; Kru&#x17E;licov&#xE1; D.; Pecher D.; Supuran C.T.; Miku\u0161 P.; Synthetic strategies and computational inhibition activity study for triazinyl-substituted benzenesulfonamide conjugates with polar and hydrophobic amino acids as inhibitors of carbonic anhydrases. Int J Mol Sci 2020,21(10),3661","journal-title":"Int J Mol Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/molecules21060808","volume":"21","author":"&#x17B;o\u0142nowska B.","year":"2016","unstructured":"&#x17B;o\u0142nowska B.; S\u0142awi\u0144ski J.; Pogorzelska A.; Szafra\u0144ski K.; Kawiak A.; Stasi\u0142oj\u0107 G.; Belka M.; Ulenberg S.; B\u0105czek T.; Chojnacki J.; Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1, 2, 4-triazin-3-yl) benzenesulfonamides: Synthesis, molecular structure, anticancer activity, apoptosis-inducing activity and metabolic stability. Molecules 2016,21(6),808","journal-title":"Molecules"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/cbdd.12955","volume":"90","author":"&#x17B;o\u0142nowska B.","year":"2017","unstructured":"&#x17B;o\u0142nowska B.; S\u0142awi\u0144ski J.; Pogorzelska A.; Szafra\u0144ski K.; Kawiak A.; Stasi\u0142oj\u0107 G.; Belka M.; Zieli\u0144ska J.; B\u0105czek T.; Synthesis, QSAR studies, and metabolic stability of novel 2-alkylthio-4-chloro-N-(5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)benzenesulfonamide derivatives as potential anticancer and apoptosis-inducing agents. Chem Biol Drug Des 2017,90(3),380-396","journal-title":"Chem Biol Drug Des"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3390\/molecules25071594","volume":"25","author":"Zheng X.","year":"2020","unstructured":"Zheng X.; Liu W.; Zhang D.; Recent advances in the synthesis of oxazole-based molecules via van leusen oxazole synthesis. Molecules 2020,25(7),1594","journal-title":"Molecules"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejmech.2017.12.044","volume":"144","author":"Zhang H-Z.","year":"2018","unstructured":"Zhang H-Z.; Zhao Z-L.; Zhou C-H.; Recent advance in oxazole-based medicinal chemistry. Eur J Med Chem 2018,144,444-492","journal-title":"Eur J Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00044-019-02365-x","volume":"28","author":"Kachaeva M.V.","year":"2019","unstructured":"Kachaeva M.V.; Pilyo S.G.; Hartline C.B.; Harden E.A.; Prichard M.N.; Zhirnov V.V.; Brovarets V.S.; In vitro activity of novel derivatives of 1, 3-oxazole-4-carboxylate and 1, 3-oxazole-4-carbonitrile against human cytomegalovirus. Med Chem Res 2019,28(8),1205-1211","journal-title":"Med Chem Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"115011","DOI":"10.1016\/j.molliq.2020.115011","volume":"323","author":"Riadi Y.","year":"2021","unstructured":"Riadi Y.; Ouerghi O.; Kaiba A.; Guionneau P.; Efficient novel eutectic-mixture-mediated synthesis of benzoxazole-linked pyrrolidin-2-one heterocycles. J Mol Liq 2021,323,115011","journal-title":"J Mol Liq"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.bioorg.2019.103382","volume":"94","author":"Desai S.","year":"2020","unstructured":"Desai S.; Desai V.; Shingade S.; In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors. Bioorg Chem 2020,94,103382","journal-title":"Bioorg Chem"},{"key":"ref=115","first-page":"69410","volume":"10","author":"Kachaeva M.","year":"2018","unstructured":"Kachaeva M.; Pilyo S.; Demydchuk B.; Prokopenko V.; Zhirnov V.; Brovarets V.; 4-Cyano-1, 3-oxazole-5-sulfonamides as novel promising anticancer lead compounds. Int J Curr Res 2018,10(5),69410-69425","journal-title":"Int J Curr Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"115086","DOI":"10.1016\/j.bmc.2019.115086","volume":"27","author":"Kalinin S.","year":"2019","unstructured":"Kalinin S.; Valtari A.; Ruponen M.; Toropainen E.; Kovalenko A.; Nocentini A.; Gureev M.; Dar\u2019in D.; Urtti A.; Supuran C.T.; Krasavin M.; Highly hydrophilic 1,3-oxazol-5-yl benzenesulfonamide inhibitors of carbonic anhydrase II for reduction of glaucoma-related intraocular pressure. Bioorg Med Chem 2019,27(21),115086","journal-title":"Bioorg Med Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1080\/21691401.2016.1241796","volume":"45","author":"Oksuzoglu E.","year":"2017","unstructured":"Oksuzoglu E.; Ertan-Bolelli T.; Can H.; Tarhan M.; Ozturk K.; Yildiz I.; Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles. Artif Cells Nanomed Biotechnol 2017,45(7),1388-1396","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s13738-020-02080-0","volume":"18","author":"Chundawat N.S.","year":"2021","unstructured":"Chundawat N.S.; Shanbhag G.S.; Chauhan N.P.S.; Chemical synthesis and molecular modeling of novel substituted N-1, 3-benzoxazol-2yl benzene sulfonamides as inhibitors of inh A enzyme and Mycobacterium tuberculosis growth. J Iran Chem Soc 2021,18(4),903-920","journal-title":"J Iran Chem Soc"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.compbiolchem.2018.04.006","volume":"74","author":"Kachaeva M.V.","year":"2018","unstructured":"Kachaeva M.V.; Hodyna D.M.; Semenyuta I.V.; Pilyo S.G.; Prokopenko V.M.; Kovalishyn V.V.; Metelytsia L.O.; Brovarets V.S.; Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents. Comput Biol Chem 2018,74,294-303","journal-title":"Comput Biol Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1002\/jhet.3711","volume":"56","author":"Kachaeva M.V.","year":"2019","unstructured":"Kachaeva M.V.; Hodyna D.M.; Obernikhina N.V.; Pilyo S.G.; Kovalenko Y.S.; Prokopenko V.M.; Kachkovsky O.D.; Brovarets V.S.; Dependence of the anticancer activity of 1, 3\u2010oxazole derivatives on the donor\/acceptor nature of his substitues. J Heterocycl Chem 2019,56(11),3122-3134","journal-title":"J Heterocycl Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e00239","DOI":"10.1128\/JVI.00239-19","volume":"93","author":"Rawle D.J.","year":"2019","unstructured":"Rawle D.J.; Li D.; Wu Z.; Wang L.; Choong M.; Lor M.; Reid R.C.; Fairlie D.P.; Harris J.; Tachedjian G.; Poulsen S.A.; Harrich D.; Oxazole-benzenesulfonamide derivatives inhibit HIV-1 reverse transcriptase interaction with cellular eEF1A and reduce viral replication. J Virol 2019,93(12),e00239-e00219","journal-title":"J Virol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00044-015-1499-1","volume":"25","author":"Ertan-Bolelli T.","year":"2016","unstructured":"Ertan-Bolelli T.; Yildiz I.; Ozgen-Ozgacar S.; Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives. Med Chem Res 2016,25(4),553-567","journal-title":"Med Chem Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"136451","DOI":"10.1016\/j.electacta.2020.136451","volume":"353","author":"Youseflouei N.","year":"2020","unstructured":"Youseflouei N.; Alizadeh S.; Masoudi-Khoram M.; Nematollahi D.; Alizadeh H.; A comprehensive electrochemical study of 2-mercaptobenzoheterocyclic derivatives. Air-assisted electrochemical synthesis of new sulfonamide derivatives. Electrochim Acta 2020,353,136451","journal-title":"Electrochim Acta"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.bmc.2018.05.013","volume":"26","author":"Zhu J.","year":"2018","unstructured":"Zhu J.; Mo J.; Lin H.Z.; Chen Y.; Sun H.P.; The recent progress of isoxazole in medicinal chemistry. Bioorg Med Chem 2018,26(12),3065-3075","journal-title":"Bioorg Med Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ejmech.2017.11.093","volume":"143","author":"Sowmya D.V.","year":"2018","unstructured":"Sowmya D.V.; Lakshmi Teja G.; Padmaja A.; Kamala Prasad V.; Padmavathi V.; Green approach for the synthesis of thiophenyl pyrazoles and isoxazoles by adopting 1,3-dipolar cycloaddition methodology and their antimicrobial activity. Eur J Med Chem 2018,143,891-898","journal-title":"Eur J Med Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejmech.2017.06.002","volume":"137","author":"Sysak A.","year":"2017","unstructured":"Sysak A.; Obmi\u0144ska-Mrukowicz B.; Isoxazole ring as a useful scaffold in a search for new therapeutic agents. Eur J Med Chem 2017,137,292-309","journal-title":"Eur J Med Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.bmc.2017.01.008","volume":"25","author":"Altug C.","year":"2017","unstructured":"Altug C.; G&#xFC;ne&#x15F; H.; Nocentini A.; Monti S.M.; Buonanno M.; Supuran C.T.; Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties. Bioorg Med Chem 2017,25(4),1456-1464","journal-title":"Bioorg Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1134\/S1070363218090207","volume":"88","author":"Arshad M.","year":"2018","unstructured":"Arshad M.; Synthesis, characterization, and antimicrobial assessment of some computationally bioactive 1, 2-oxazole derivatives. Russ J Gen Chem 2018,88(9),1886-1891","journal-title":"Russ J Gen Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1747-0285.2010.00956.x","volume":"75","author":"Loh B.","year":"2010","unstructured":"Loh B.; Vozzolo L.; Mok B.J.; Lee C.C.; Fitzmaurice R.J.; Caddick S.; Fassati A.; Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides. Chem Biol Drug Des 2010,75(5),461-474","journal-title":"Chem Biol Drug Des"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.molstruc.2018.08.087","volume":"1176","author":"Fahim A.M.","year":"2019","unstructured":"Fahim A.M.; Shalaby M.A.; Synthesis, biological evaluation, molecular docking and DFT calculations of novel benzenesulfonamide derivatives. J Mol Struct 2019,1176,408-421","journal-title":"J Mol Struct"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1016\/j.bmcl.2018.08.040","volume":"28","author":"da Rosa R.","year":"2018","unstructured":"da Rosa R.; Zimmermann L.A.; de Moraes M.H.; Schneider N.F.Z.; Schappo A.D.; Sim&#xF5;es C.M.O.; Steindel M.; Schenkel E.P.; Bernardes L.S.C.; Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus. Bioorg Med Chem Lett 2018,28(20),3381-3384","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1515\/chempap-2015-0109","volume":"69","author":"Kr&#xE1;tk&#xFD; M.","year":"2015","unstructured":"Kr&#xE1;tk&#xFD; M.; Mand&#xED;kov&#xE1; J.; Trejtnar F.; Buchta V.; Stola\u0159&#xED;kov&#xE1; J.; Vin\u0161ov&#xE1; J.; Synthesis and antimicrobial activity of sulphamethoxazole-based ureas and imidazolidine-2,4,5-triones. Chem Pap 2015,69(8),1108-1117","journal-title":"Chem Pap"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/cbdd.13795","volume":"97","author":"Vaidya A.","year":"2021","unstructured":"Vaidya A.; Pathak D.; Shah K.; 1,3,4-oxadiazole and its derivatives: A review on recent progress in anticancer activities. Chem Biol Drug Des 2021,97(3),572-591","journal-title":"Chem Biol Drug Des"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.3390\/molecules23123361","volume":"23","author":"Glomb T.","year":"2018","unstructured":"Glomb T.; Szymankiewicz K.; &#x15A;wi\u0105tek P.; Anti-cancer activity of derivatives of 1, 3, 4-oxadiazole. Molecules 2018,23(12),3361","journal-title":"Molecules"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"127136","DOI":"10.1016\/j.bmcl.2020.127136","volume":"30","author":"Kashid B.B.","year":"2020","unstructured":"Kashid B.B.; Salunkhe P.H.; Dongare B.B.; More K.R.; Khedkar V.M.; Ghanwat A.A.; Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study. Bioorg Med Chem Lett 2020,30(12),127136","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cbi.2015.08.018","volume":"240","author":"Gobec M.","year":"2015","unstructured":"Gobec M.; Toma\u0161i&#x10D; T.; Markovi&#x10D; T.; Mlinari&#x10D;-Ra\u0161&#x10D;an I.; Dolenc M.S.; Jakopin &#x17D;.; Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol. Chem Biol Interact 2015,240,200-207","journal-title":"Chem Biol Interact"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.compbiolchem.2019.03.002","volume":"80","author":"Ambhore A.N.","year":"2019","unstructured":"Ambhore A.N.; Kamble S.S.; Kadam S.N.; Kamble R.D.; Hebade M.J.; Hese S.V.; Gaikwad M.V.; Meshram R.J.; Gacche R.N.; Dawane B.S.; Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent. Comput Biol Chem 2019,80,54-65","journal-title":"Comput Biol Chem"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1472197","DOI":"10.1080\/23312009.2018.1472197","volume":"4","author":"Rehman A.","year":"2018","unstructured":"Rehman A.; Nafeesa K.; Abbasi M.A.; Siddiqui S.Z.; Rasool S.; Shah S.A.A.; Ashraf M.; Synthesis of new heterocyclic 3-piperidinyl-1, 3, 4-oxadiazole derivatives as potential drug candidate for the treatment of Alzheimer\u2019s disease. Cogent Chem 2018,4(1),1472197","journal-title":"Cogent Chem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"112059","DOI":"10.1016\/j.ejmech.2020.112059","volume":"189","author":"Song X.","year":"2020","unstructured":"Song X.; Sun P.; Wang J.; Guo W.; Wang Y.; Meng L.H.; Liu H.; Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors. Eur J Med Chem 2020,189,112059","journal-title":"Eur J Med Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10426500600919074","volume":"182","author":"Zareef M.","year":"2007","unstructured":"Zareef M.; Iqbal R.; Al-Masoudi N.A.; Zaidi J.H.; Arfan M.; Shahzad S.A.; Synthesis, anti\u2013HIV, and antifungal activity of new benzensulfonamides bearing the 2, 5-disubstituted-1, 3, 4-oxadiazole moiety. Phosphorus Sulfur Silicon Relat Elem 2007,182(2),281-298","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/S1984-82502016000100009","volume":"52","author":"Sattar A.","year":"2016","unstructured":"Sattar A.; Abbasi M.A.; Siddiqui S.Z.; Rasool S.; Ahmad I.; Synthesis of some novel enzyme inhibitors and antibacterial agents derived from 5-(1-(4-tosyl) piperidin-4-yl)-1, 3, 4-oxadiazol-2-thiol. Braz J Pharm Sci 2016,52(1),77-85","journal-title":"Braz J Pharm Sci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.4314\/tjpr.v15i6.20","volume":"15","author":"Sattar A.","year":"2016","unstructured":"Sattar A.; Abbasi M.; Siddiqi S.; Nafeesa K.; Ahmad I.; Synthesis and antibacterial study of some s-substituted aliphatic analogues of 2-mercapto-5-(1-(4-toluenesulfonyl) piperidin-4-yl)-1, 3, 4-oxadiazole. Trop J Pharm Res 2016,15(6),1267-1274","journal-title":"Trop J Pharm Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.4067\/S0717-97072017000100013","volume":"62","author":"Ahtzaz S.","year":"2017","unstructured":"Ahtzaz S.; Abbasi M.A.; Siddiqui S.Z.; Rasool S.; Ahmad I.; Synthesis, spectral analysis and antibacterial evaluation of 5-substituted-1, 3, 4-oxadiazol-2-yl 4-(4-methylpiperidin-1-ylsulfonyl) benzyl sulfides. J Chil Chem Soc 2017,62(1),3370-3375","journal-title":"J Chil Chem Soc"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4314\/bcse.v33i2.11","volume":"33","author":"Kavitha S.","year":"2019","unstructured":"Kavitha S.; Nasarullah Z.; Kannan K.; Synthesis and biological evaluation of sulfonamide-based 1, 3, 4-oxadiazole derivatives. Bull Chem Soc Ethiop 2019,33(2),307-319","journal-title":"Bull Chem Soc Ethiop"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejmech.2017.03.039","volume":"132","author":"S\u0142awi\u0144ski J.","year":"2017","unstructured":"S\u0142awi\u0144ski J.; Szafra\u0144ski K.; Pogorzelska A.; &#x17B;o\u0142nowska B.; Kawiak A.; Macur K.; Belka M.; B\u0105czek T.; Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability. Eur J Med Chem 2017,132,236-248","journal-title":"Eur J Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bioorg.2017.10.005","volume":"76","author":"Krasavin M.","year":"2018","unstructured":"Krasavin M.; Shetnev A.; Sharonova T.; Baykov S.; Tuccinardi T.; Kalinin S.; Angeli A.; Supuran C.T.; Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms. Bioorg Chem 2018,76,88-97","journal-title":"Bioorg Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jsps.2016.07.004","volume":"25","author":"Kavitha S.","year":"2017","unstructured":"Kavitha S.; Kannan K.; Gnanavel S.; Synthesis, characterization and biological evaluation of novel 2,5 substituted-1,3,4 oxadiazole derivatives. Saudi Pharm J 2017,25(3),337-345","journal-title":"Saudi Pharm J"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/acsmedchemlett.7b00205","volume":"8","author":"Bianco G.","year":"2017","unstructured":"Bianco G.; Meleddu R.; Distinto S.; Cottiglia F.; Gaspari M.; Melis C.; Corona A.; Angius R.; Angeli A.; Taverna D.; Alcaro S.; Leitans J.; Kazaks A.; Tars K.; Supuran C.T.; Maccioni E.; N-Acylbenzenesulfonamide dihydro-1, 3, 4-oxadiazole hybrids: Seeking selectivity toward carbonic anhydrase isoforms. ACS Med Chem Lett 2017,8(8),792-796","journal-title":"ACS Med Chem Lett"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejmech.2014.11.011","volume":"90","author":"Gamal El-Din M.M.","year":"2015","unstructured":"Gamal El-Din M.M.; El-Gamal M.I.; Abdel-Maksoud M.S.; Yoo K.H.; Oh C-H.; Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety. Eur J Med Chem 2015,90,45-52","journal-title":"Eur J Med Chem"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"103852","DOI":"10.1016\/j.bioorg.2020.103852","volume":"99","author":"Javid N.","year":"2020","unstructured":"Javid N.; Munir R.; Chaudhry F.; Imran A.; Zaib S.; Muzaffar A.; Iqbal J.; Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition. Bioorg Chem 2020,99,103852","journal-title":"Bioorg Chem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"127038","DOI":"10.1016\/j.bmcl.2020.127038","volume":"30","author":"Liu C.","year":"2020","unstructured":"Liu C.; Nan Y.; Xia Z.; Gu K.; Chen C.; Dong X.; Ju D.; Zhao W.; Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy. Bioorg Med Chem Lett 2020,30(8),127038","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.bmcl.2016.04.058","volume":"26","author":"Mochona B.","year":"2016","unstructured":"Mochona B.; Qi X.; Euynni S.; Sikazwi D.; Mateeva N.; Soliman K.F.; Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Bioorg Med Chem Lett 2016,26(12),2847-2851","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21608\/rpbs.2018.23373","volume":"2","author":"Salem I.M.","year":"2018","unstructured":"Salem I.M.; Mostafa S.M.; El-Sabbag O.I.; Ibrahim T.S.; Abdulrahmanf A.; Bendary M.M.; Synthesis and antimicrobial evaluation of novel hydrazones and 1, 3, 4-oxadiazoles incorporating bumetanide derivatives. Rec Pharm Biomed Sci 2018,2(2),52-66","journal-title":"Rec Pharm Biomed Sci"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"112219","DOI":"10.1016\/j.ejmech.2020.112219","volume":"193","author":"Sharma V.","year":"2020","unstructured":"Sharma V.; Kumar R.; Angeli A.; Supuran C.T.; Sharma P.K.; Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes. Eur J Med Chem 2020,193,112219","journal-title":"Eur J Med Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"126677","DOI":"10.1016\/j.bmcl.2019.126677","volume":"29","author":"Shetnev A.","year":"2019","unstructured":"Shetnev A.; Shlenev R.; Efimova J.; Ivanovskii S.; Tarasov A.; Petzer A.; Petzer J.P.; 1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B. Bioorg Med Chem Lett 2019,29(21),126677","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bioorg.2017.01.015","volume":"71","author":"Taha M.","year":"2017","unstructured":"Taha M.; Baharudin M.S.; Ismail N.H.; Selvaraj M.; Salar U.; Alkadi K.A.; Khan K.M.; Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As &#x3B2;-glucuronidase inhibitors. Bioorg Chem 2017,71,86-96","journal-title":"Bioorg Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1134\/S1070363218040278","volume":"88","author":"Bhargavi M.V.","year":"2018","unstructured":"Bhargavi M.V.; Shashikala P.; Sumakanth M.; Krishna C.; Synthesis, molecular docking, analgesic, and anti-inflammatory activities of new 1, 2, 4-oxadiazolo-sulfonamides. Russ J Gen Chem 2018,88(4),804-811","journal-title":"Russ J Gen Chem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"126874","DOI":"10.1016\/j.bmcl.2019.126874","volume":"30","author":"Yang C.","year":"2020","unstructured":"Yang C.; Feng Y.; Yang X.; Sun M.; Li Z.; Liu X.; Lu L.; Sun X.; Zhang J.; He X.; Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2020,30(2),126874","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/14756366.2018.1443447","volume":"33","author":"Angapelly S.","year":"2018","unstructured":"Angapelly S.; Ramya P.V.S.; Sodhi R.; Angeli A.; Rangan K.; Nagesh N.; Supuran C.T.; Arifuddin M.; Iodine-mediated one-pot intramolecular decarboxylation domino reaction for accessing functionalised 2-(1,3,4-oxadiazol-2-yl)anilines with carbonic anhydrase inhibitory action. J Enzyme Inhib Med Chem 2018,33(1),615-628","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00044-014-1277-5","volume":"24","author":"Padmaja A.","year":"2015","unstructured":"Padmaja A.; Pedamalakondaiah D.; Sravya G.; Reddy G.M.; Kumar M.V.J.; Synthesis and antioxidant activity of a new class of sulfone\/sulfonamide-linked bis(oxadiazoles), bis(thiadiazoles), and bis(triazoles). Med Chem Res 2015,24(5),2011-2020","journal-title":"Med Chem Res"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"83","DOI":"10.11648\/j.sjc.20180605.12","volume":"6","author":"Hossain M.","year":"2018","unstructured":"Hossain M.; Nanda A.K.; A review on heterocyclic: Synthesis and their application in medicinal chemistry of imidazole moiety. Sci J Chem 2018,6(5),83","journal-title":"Sci J Chem"},{"key":"ref=162","first-page":"36","volume":"1","author":"Shalini K.","year":"2010","unstructured":"Shalini K.; Sharma P.K.; Kumar N.; Imidazole and its biological activities: A review. Chem Sin 2010,1(3),36-47","journal-title":"Chem Sin"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejmech.2018.03.016","volume":"150","author":"Fan Y-L.","year":"2018","unstructured":"Fan Y-L.; Jin X-H.; Huang Z-P.; Yu H-F.; Zeng Z-G.; Gao T.; Feng L-S.; Recent advances of imidazole-containing derivatives as anti-tubercular agents. Eur J Med Chem 2018,150,347-365","journal-title":"Eur J Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1039\/C7MD00067G","volume":"8","author":"Ali I.","year":"2017","unstructured":"Ali I.; Lone M.N.; Aboul-Enein H.Y.; Imidazoles as potential anticancer agents. MedChemComm 2017,8(9),1742-1773","journal-title":"MedChemComm"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"11978","DOI":"10.3390\/molecules181011978","volume":"18","author":"Al-Mohammed N.N.","year":"2013","unstructured":"Al-Mohammed N.N.; Alias Y.; Abdullah Z.; Shakir R.M.; Taha E.M.; Hamid A.A.; Synthesis and antibacterial evaluation of some novel imidazole and benzimidazole sulfonamides. Molecules 2013,18(10),11978-11995","journal-title":"Molecules"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1002\/slct.202001449","volume":"5","author":"Dende S.K.","year":"2020","unstructured":"Dende S.K.; Korupolu R.B.; Leleti K.R.; Design and synthesis of sulfonamide\u2010attached 2\u2010(isoxazol\u20103\u2010yl)\u20101H\u2010imidazoles as anticancer agents. ChemistrySelect 2020,5(26),7919-7922","journal-title":"ChemistrySelect"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"e2000375","DOI":"10.1002\/ardp.202000375","volume":"354","author":"Tugrak M.","year":"2021","unstructured":"Tugrak M.; Gul H.I.; Demir Y.; Levent S.; Gulcin I.; Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides. Arch Pharm (Weinheim) 2021,354(4),e2000375","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5267\/j.ccl.2019.5.003","volume":"8","author":"Shablykin O.","year":"2019","unstructured":"Shablykin O.; Kornii Y.; Dyakonenko V.; Shablykina O.; Brovarets V.; Synthesis and anticancer activity of new substituted imidazolidinone sulfonamides. Curr Chem Lett 2019,8(4),199-210","journal-title":"Curr Chem Lett"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"103438","DOI":"10.1016\/j.bioorg.2019.103438","volume":"99","author":"Metwally N.H.","year":"2020","unstructured":"Metwally N.H.; Mohamed M.S.; New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study. Bioorg Chem 2020,99,103438","journal-title":"Bioorg Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14756366.2019.1685510","volume":"35","author":"Aspatwar A.","year":"2020","unstructured":"Aspatwar A.; Parvathaneni N.K.; Barker H.; Anduran E.; Supuran C.T.; Dubois L.; Lambin P.; Parkkila S.; Winum J-Y.; Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series. J Enzyme Inhib Med Chem 2020,35(1),109-117","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"938486","DOI":"10.1155\/2015\/938486","volume":"2015","author":"Abdul Qadir M.","year":"2015","unstructured":"Abdul Qadir M.; Ahmed M.; Iqbal M.; Synthesis, characterization, and antibacterial activities of novel sulfonamides derived through condensation of amino group containing drugs, amino acids, and their analogs. BioMed Res Int 2015,2015,938486","journal-title":"BioMed Res Int"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/14756366.2017.1327522","volume":"32","author":"De Vita D.","year":"2017","unstructured":"De Vita D.; Angeli A.; Pandolfi F.; Bortolami M.; Costi R.; Di Santo R.; Suffredini E.; Ceruso M.; Del Prete S.; Capasso C.; Scipione L.; Supuran C.T.; Inhibition of the &#x3B1;-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties. J Enzyme Inhib Med Chem 2017,32(1),798-804","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bioorg.2018.09.037","volume":"82","author":"Georgey H.H.","year":"2019","unstructured":"Georgey H.H.; Manhi F.M.; Mahmoud W.R.; Mohamed N.A.; Berrino E.; Supuran C.T.; 1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity. Bioorg Chem 2019,82,109-116","journal-title":"Bioorg Chem"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3390\/molecules25102347","volume":"25","author":"Anduran E.","year":"2020","unstructured":"Anduran E.; Aspatwar A.; Parvathaneni N-K.; Suylen D.; Bua S.; Nocentini A.; Parkkila S.; Supuran C.T.; Dubois L.; Lambin P.; Winum J.Y.; Hypoxia-activated prodrug derivatives of carbonic anhydrase inhibitors in benzenesulfonamide series: Synthesis and biological evaluation. Molecules 2020,25(10),2347","journal-title":"Molecules"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","volume":"179","author":"Allam H.A.","year":"2019","unstructured":"Allam H.A.; Fahim S.H.F.; Abo-Ashour M.; Nocentini A.; Elbakry M.E.; Abdelrahman M.A.; Eldehna W.M.; Ibrahim H.S.; Supuran C.T.; Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX. Eur J Med Chem 2019,179,547-556","journal-title":"Eur J Med Chem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14756366.2016.1178248","volume":"31","author":"Supuran C.T.","year":"2016","unstructured":"Supuran C.T.; Kalinin S.; Tan&#xE7; M.; Sarnpitak P.; Mujumdar P.; Poulsen S-A.; Krasavin M.; Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases. J Enzyme Inhib Med Chem 2016,31(Sup. 1),197-202","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1039\/C4NJ01932F","volume":"39","author":"Zhang H-Z.","year":"2015","unstructured":"Zhang H-Z.; Jeyakkumar P.; Kumar K.V.; Zhou C-H.; Synthesis of novel sulfonamide azoles via C\u2013N cleavage of sulfonamides by azole ring and relational antimicrobial study. New J Chem 2015,39(7),5776-5796","journal-title":"New J Chem"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cbdd.12462","volume":"86","author":"Keri R.S.","year":"2015","unstructured":"Keri R.S.; Hiremathad A.; Budagumpi S.; Nagaraja B.M.; Comprehensive review in current developments of benzimidazole\u2010based medicinal chemistry. Chem Biol Drug Des 2015,86(1),19-65","journal-title":"Chem Biol Drug Des"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","volume":"97","author":"Yadav G.","year":"2015","unstructured":"Yadav G.; Ganguly S.; Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review. Eur J Med Chem 2015,97,419-443","journal-title":"Eur J Med Chem"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3329\/icpj.v1i5.10284","volume":"1","author":"Singh N.","year":"2012","unstructured":"Singh N.; Pandurangan A.; Rana K.; Anand P.; Ahamad A.; Tiwari A.K.; Benzimidazole: A short review of their antimicrobial activities. Int Curr Pharm J 2012,1(5),110-118","journal-title":"Int Curr Pharm J"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejmech.2017.05.064","volume":"137","author":"El-Gohary N.S.","year":"2017","unstructured":"El-Gohary N.S.; Shaaban M.I.; Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. Eur J Med Chem 2017,137,439-449","journal-title":"Eur J Med Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejmech.2017.04.077","volume":"136","author":"Zhang H-Z.","year":"2017","unstructured":"Zhang H-Z.; He S-C.; Peng Y-J.; Zhang H-J.; Gopala L.; Tangadanchu V.K.R.; Gan L-L.; Zhou C-H.; Design, synthesis and antimicrobial evaluation of novel benzimidazole-incorporated sulfonamide analogues. Eur J Med Chem 2017,136,165-183","journal-title":"Eur J Med Chem"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.1021\/ja101088j","volume":"132","author":"Rouffet M.","year":"2010","unstructured":"Rouffet M.; de Oliveira C.A.F.; Udi Y.; Agrawal A.; Sagi I.; McCammon J.A.; Cohen S.M.; From sensors to silencers: Quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases. J Am Chem Soc 2010,132(24),8232-8233","journal-title":"J Am Chem Soc"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/14756366.2012.757223","volume":"29","author":"Zubrien\u0117 A.","year":"2014","unstructured":"Zubrien\u0117 A.; &#x10C;apkauskait\u0117 E.; Gylyt\u0117 J.; Ki\u0161onait\u0117 M.; Tumkevi&#x10D;ius S.; Matulis D.; Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII. J Enzyme Inhib Med Chem 2014,29(1),124-131","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bmc.2017.12.035","volume":"26","author":"&#x10C;apkauskait\u0117 E.","year":"2018","unstructured":"&#x10C;apkauskait\u0117 E.; Zak\u0161auskas A.; Ruibys V.; Linkuvien\u0117 V.; Paketuryt\u0117 V.; Gedgaudas M.; Kairys V.; Matulis D.; Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors. Bioorg Med Chem 2018,26(3),675-687","journal-title":"Bioorg Med Chem"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1573408015666190402100338","volume":"15","author":"Singh S.","year":"2019","unstructured":"Singh S.; 3D-QSAR CoMFA Studies on benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases XII as antitumor agents. Curr Enzym Inhib 2019,15(1),69-77","journal-title":"Curr Enzym Inhib"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1080\/14756366.2019.1666836","volume":"34","author":"Milite C.","year":"2019","unstructured":"Milite C.; Amendola G.; Nocentini A.; Bua S.; Cipriano A.; Barresi E.; Feoli A.; Novellino E.; Da Settimo F.; Supuran C.T.; Castellano S.; Cosconati S.; Taliani S.; Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: Synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies. J Enzyme Inhib Med Chem 2019,34(1),1697-1710","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1002\/slct.201700531","volume":"2","author":"&#x10C;apkauskait\u0117 E.","year":"2017","unstructured":"&#x10C;apkauskait\u0117 E.; Linkuvien\u0117 V.; Smirnov A.; Milinavi&#x10D;i&#x16B;t\u0117 G.; Timm D.D.; Kasiliauskait\u0117 A.; Manakova E.; Gra&#x17E;ulis S.; Matulis D.; Combinatorial design of isoform\u2010selective N\u2010alkylated benzimidazole\u2010based inhibitors of carbonic anhydrases. ChemistrySelect 2017,2(19),5360-5371","journal-title":"ChemistrySelect"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1016\/j.bmc.2018.05.015","volume":"26","author":"Naaz F.","year":"2018","unstructured":"Naaz F.; Srivastava R.; Singh A.; Singh N.; Verma R.; Singh V.K.; Singh R.K.; Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole. Bioorg Med Chem 2018,26(12),3414-3428","journal-title":"Bioorg Med Chem"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.bmcl.2018.11.045","volume":"29","author":"Ma T.","year":"2019","unstructured":"Ma T.; Huang M.; Li A.; Zhao F.; Li D.; Liu D.; Zhao L.; Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors. Bioorg Med Chem Lett 2019,29(14),1859-1863","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"111731","DOI":"10.1016\/j.ejmech.2019.111731","volume":"183","year":"2019","unstructured":"Gao, Q.L.; Wu, B.W.; Li, D.; Shi, L.; Zhu, T.; Lou, J.F.; Jin, C.Y.; Zhang, Y.B.; Zhang, S.Y.; Liu, H.M. Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: Design, synthesis and SAR studies. Eur J Med Chem 2019,183,111731","journal-title":"Eur J Med Chem"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1016\/j.bmcl.2017.05.017","volume":"27","author":"Sharma R.","year":"2017","unstructured":"Sharma R.; Bali A.; Chaudhari B.B.; Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing anti-inflammatory agents with antioxidant effect. Bioorg Med Chem Lett 2017,27(13),3007-3013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12539-016-0207-2","volume":"10","author":"Singh A.","year":"2018","unstructured":"Singh A.; Srivastava R.; Singh R.K.; Design, synthesis, and antibacterial activities of novel heterocyclic arylsulphonamide derivatives. Interdiscip Sci 2018,10(4),748-761","journal-title":"Interdiscip Sci"},{"key":"ref=194","first-page":"48","volume":"5","author":"Banerjee R.","year":"2015","unstructured":"Banerjee R.; Kumar H.; Banerjee M.; Medicinal significance of furan derivatives: A review. Int J Res Phytochem Pharmacol 2015,5(3),48-57","journal-title":"Int J Res Phytochem Pharmacol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1016\/S0040-4039(01)01984-0","volume":"42","author":"Zeni G.","year":"2001","unstructured":"Zeni G.; L&#xFC;dtke D.S.; Nogueira C.W.; Panatieri R.B.; Braga A.L.; Silveira C.C.; Stefani H.A.; Rocha J.B.T.; New acetylenic furan derivatives: Synthesis and anti-inflammatory activity. Tetrahedron Lett 2001,42(51),8927-8930","journal-title":"Tetrahedron Lett"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bjbas.2017.08.001","volume":"6","author":"Malladi S.","year":"2017","unstructured":"Malladi S.; Nadh R.V.; Babu K.S.; Babu P.S.; Synthesis and antibacterial activity studies of 2, 4-di substituted furan derivatives. Beni Suef Univ J Basic Appl Sci 2017,6(4),345-353","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"115","DOI":"10.17628\/ecb.2019.8.115-122","volume":"8","author":"Desmukh S.","year":"2019","unstructured":"Desmukh S.; Pawar C.D.; Pansare D.N.; Chavan S.L.; Pawar R.; Ubale M.; synthesis and antimicrobial screening of 5-(substituted phenyl)-N-(2-oxo-2-(substituted phenyl) ethyl)-N-methylfuran-2-sulfonamide derivatives. Eur Chem Bull 2019,8(4),115-122","journal-title":"Eur Chem Bull"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1134\/S1070363219030204","volume":"89","author":"Purna Chander Rao G.","year":"2019","unstructured":"Purna Chander Rao G.; Ramesh V.; Ramachandran D.; Kalyan Chakravarthy A.; Design, synthesis and anticancer evaluation of novel furan sulphonamide derivatives. Russ J Gen Chem 2019,89(3),486-491","journal-title":"Russ J Gen Chem"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1080\/07391102.2020.1792345","volume":"39","author":"Celebioglu H.U.","year":"2021","unstructured":"Celebioglu H.U.; Erden Y.; Hamurcu F.; Taslimi P.; &#x15E;ent&#xFC;rk O.S.; &#xD6;zmen &#xDC;.&#xD6;.; Tuzun B.; Gul&#xE7;in \u0130.; Cytotoxic effects, carbonic anhydrase isoenzymes, &#x3B1;-glycosidase and acetylcholinesterase inhibitory properties, and molecular docking studies of heteroatom-containing sulfonyl hydrazone derivatives. J Biomol Struct Dyn 2021,39(15),5539-5550","journal-title":"J Biomol Struct Dyn"},{"key":"ref=200","first-page":"120","volume":"142","author":"Meena L.R.","year":"2020","unstructured":"Meena L.R.; Sharma V.S.; Swarnkar P.; Synthesis and biological activity of novel sulfonamides derivatives of various heterocyclic compounds. World Sci News 2020,142,120-134","journal-title":"World Sci News"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molstruc.2015.10.054","volume":"1105","author":"G&#xFC;nd&#xFC;zalp A.B.","year":"2016","unstructured":"G&#xFC;nd&#xFC;zalp A.B.; Parlakg&#xFC;m&#xFC;&#x15F; G.; Uzun D.; &#xD6;zmen &#xDC;.&#xD6;.; &#xD6;zbek N.; Sar\u0131 M.; Tun&#xE7; T.; Carbonic anhydrase inhibitors: Synthesis, characterization and inhibition activities of furan sulfonylhydrazones against carbonic anhydrase I (hCA I). J Mol Struct 2016,1105,332-340","journal-title":"J Mol Struct"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejmech.2014.10.085","volume":"97","author":"Nevagi R.J.","year":"2015","unstructured":"Nevagi R.J.; Dighe S.N.; Dighe S.N.; Biological and medicinal significance of benzofuran. Eur J Med Chem 2015,97,561-581","journal-title":"Eur J Med Chem"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/13543776.2019.1673727","volume":"29","author":"Dawood K.M.","year":"2019","unstructured":"Dawood K.M.; An update on benzofuran inhibitors: A patent review. Expert Opin Ther Pat 2019,29(11),841-870","journal-title":"Expert Opin Ther Pat"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharep.2016.11.007","volume":"69","author":"Chand K.","year":"2017","unstructured":"Chand K.; Rajeshwari; Hiremathad, A.; Singh, M.; Santos, M.A.; Keri, R.S. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives. Pharmacol Rep 2017,69(2),281-295","journal-title":"Pharmacol Rep"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"E1529","DOI":"10.3390\/molecules24081529","volume":"24","author":"Napi&#xF3;rkowska M.","year":"2019","unstructured":"Napi&#xF3;rkowska M.; Cie&#x15B;lak M.; Ka&#x17A;mierczak-Bara\u0144ska J.; Kr&#xF3;lewska-Goli\u0144ska K.; Nawrot B.; Synthesis of new derivatives of benzofuran as potential anticancer agents. Molecules 2019,24(8),E1529","journal-title":"Molecules"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1016\/j.bmcl.2016.06.055","volume":"26","author":"Mao Z-W.","year":"2016","unstructured":"Mao Z-W.; Zheng X.; Lin Y-P.; Hu C-Y.; Wang X-L.; Wan C-P.; Rao G-X.; Design, synthesis and anticancer activity of novel hybrid compounds between benzofuran and N-aryl piperazine. Bioorg Med Chem Lett 2016,26(15),3421-3424","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.bmcl.2014.03.087","volume":"24","author":"Yadav P.","year":"2014","unstructured":"Yadav P.; Singh P.; Tewari A.K.; Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs. Bioorg Med Chem Lett 2014,24(10),2251-2255","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.025","volume":"162","author":"Xu Z.","year":"2019","unstructured":"Xu Z.; Zhao S.; Lv Z.; Feng L.; Wang Y.; Zhang F.; Bai L.; Deng J.; Benzofuran derivatives and their anti-tubercular, anti-bacterial activities. Eur J Med Chem 2019,162,266-276","journal-title":"Eur J Med Chem"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/14756366.2019.1697250","volume":"35","author":"Abdelrahman M.A.","year":"2020","unstructured":"Abdelrahman M.A.; Eldehna W.M.; Nocentini A.; Ibrahim H.S.; Almahli H.; Abdel-Aziz H.A.; Abou-Seri S.M.; Supuran C.T.; Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: Synthesis and in vitro biological evaluation. J Enzyme Inhib Med Chem 2020,35(1),298-305","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"346","DOI":"10.13171\/mjc751912061355msaeg","volume":"7","author":"El-Gaby M.S.","year":"2018","unstructured":"El-Gaby M.S.; Hassan M.I.; Hussein M.F.; Ali A.M.; Elaasser M.M.; Faraghally F.A.; Synthesis, characterization and in vitro biological screening of 4-hydroxy naphthalen-1-yl, naphtho [1, 2-b] furan, benzo [h] chromene and 5, 6-dihydropyridazine derivatives containing sulfonamide moiety. Mediterr J Chem 2018,7(5),346-358","journal-title":"Mediterr J Chem"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.bmc.2016.06.021","volume":"25","author":"Wei J.","year":"2017","unstructured":"Wei J.; Yang Y.; Li Y.; Mo X.; Guo X.; Zhang X.; Xu X.; Jiang Z.; You Q.; Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential. Bioorg Med Chem 2017,25(6),1737-1746","journal-title":"Bioorg Med Chem"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"115659","DOI":"10.1016\/j.bmc.2020.115659","volume":"28","author":"Thompson J.C.","year":"2020","unstructured":"Thompson J.C.; Dao W.T.; Ku A.; Rodriguez-Beltran S.L.; Amezcua M.; Palomino A.Y.; Lien T.; Salzameda N.T.; Synthesis and activity of isoleucine sulfonamide derivatives as novel botulinum neurotoxin serotype A light chain inhibitors. Bioorg Med Chem 2020,28(18),115659","journal-title":"Bioorg Med Chem"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.bmcl.2016.12.059","volume":"27","author":"Kawai T.","year":"2017","unstructured":"Kawai T.; Kazuhiko I.; Takaya N.; Yamaguchi Y.; Kishii R.; Kohno Y.; Kurasaki H.; Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents. Bioorg Med Chem Lett 2017,27(4),1045-1049","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.bmcl.2017.01.001","volume":"27","author":"Jernigan F.E.","year":"2017","unstructured":"Jernigan F.E.; Hanai J.I.; Sukhatme V.P.; Sun L.; Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening. Bioorg Med Chem Lett 2017,27(4),929-935","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3987\/COM-15-13281","volume":"91","author":"Al-Harbi S.A.","year":"2015","unstructured":"Al-Harbi S.A.; Bashandy M.S.; Synthesis, antimicrobial and antihuman liver cancer activities of novel sulfonamides incorporating benzofuran, pyrazole, pyrimidine, 1, 4-diazepine and pyridine moieties prepared from (E)-4-(3-(dimethylamino) acryloyl)-N-ethyl-N-methylbenzenesulfo-] namide. Heterocycles 2015,91(10),1905-1925","journal-title":"Heterocycles"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13065-018-0511-5","volume":"12","author":"Shah R.","year":"2018","unstructured":"Shah R.; Verma P.K.; Therapeutic importance of synthetic thiophene. Chem Cent J 2018,12(1),137","journal-title":"Chem Cent J"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/jhet.3249","volume":"55","author":"Mishra R.","year":"2018","unstructured":"Mishra R.; Sachan N.; Kumar N.; Mishra I.; Chand P.; Thiophene scaffold as prospective antimicrobial agent: A review. J Heterocycl Chem 2018,55(9),2019-2034","journal-title":"J Heterocycl Chem"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13065-019-0569-8","volume":"13","author":"Shah R.","year":"2019","unstructured":"Shah R.; Verma P.K.; Synthesis of thiophene derivatives and their anti-microbial, antioxidant, anticorrosion and anticancer activity. BMC Chem 2019,13(1),54","journal-title":"BMC Chem"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/CAD.0000000000000581","volume":"29","author":"Dos Santos F.A.","year":"2018","unstructured":"Dos Santos F.A.; Pereira M.C.; de Oliveira T.B.; Mendon&#xE7;a Junior, F.J.B.; de Lima M.D.C.A.; Pitta M.G.D.R.; Pitta I.D.R.; de Melo R&#xEA;go M.J.B.; da Rocha Pitta M.G.; Anticancer properties of thiophene derivatives in breast cancer MCF-7 cells. Anticancer Drugs 2018,29(2),157-166","journal-title":"Anticancer Drugs"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1016\/j.bmcl.2010.05.039","volume":"20","author":"Caridha D.","year":"2010","unstructured":"Caridha D.; Kathcart A.K.; Jirage D.; Waters N.C.; Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases. Bioorg Med Chem Lett 2010,20(13),3863-3867","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1124\/jpet.109.152975","volume":"331","author":"Martone R.L.","year":"2009","unstructured":"Martone R.L.; Zhou H.; Atchison K.; Comery T.; Xu J.Z.; Huang X.; Gong X.; Jin M.; Kreft A.; Harrison B.; Mayer S.C.; Aschmies S.; Gonzales C.; Zaleska M.M.; Riddell D.R.; Wagner E.; Lu P.; Sun S.C.; Sonnenberg-Reines J.; Oganesian A.; Adkins K.; Leach M.W.; Clarke D.W.; Huryn D.; Abou-Gharbia M.; Magolda R.; Bard J.; Frick G.; Raje S.; Forlow S.B.; Balliet C.; Burczynski M.E.; Reinhart P.H.; Wan H.I.; Pangalos M.N.; Jacobsen J.S.; Begacestat (GSI-953): A novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer\u2019s disease. J Pharmacol Exp Ther 2009,331(2),598-608","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"S403","DOI":"10.1016\/j.jscs.2014.04.007","volume":"21","author":"Noreen M.","year":"2017","unstructured":"Noreen M.; Rasool N.; Gull Y.; Zahoor A.F.; Yaqoob A.; Kousar S.; Zubair M.; Bukhari I.H.; Rana U.A.; A facile synthesis of new 5-aryl-thiophenes bearing sulfonamide moiety via Pd (0)-catalyzed Suzuki\u2013Miyaura cross coupling reactions and 5-bromothiophene-2-acetamide: As potent urease inhibitor, antibacterial agent and hemolytically active compounds. J Saudi Chem Soc 2017,21,S403-S414","journal-title":"J Saudi Chem Soc"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/10426507.2015.1100183","volume":"191","author":"Fadda A.A.","year":"2016","unstructured":"Fadda A.A.; El-badraw A.M.; Refat H.M.; Abdel-Latif E.; Synthesis of some new 2-substituted-4-sulfamoylphe-] nylazo-thiophene and\/or thiazole derivatives as antibacterial agents. Phosphorus Sulfur Silicon Relat Elem 2016,191(5),778-785","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1007\/s43440-020-00149-4","volume":"72","author":"Al\u0131m Z.","year":"2020","unstructured":"Al\u0131m Z.; K&#xF6;ksal Z.; Karaman M.; Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies. Pharmacol Rep 2020,72(6),1738-1748","journal-title":"Pharmacol Rep"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejmech.2015.08.030","volume":"103","author":"Abdelsamie A.S.","year":"2015","unstructured":"Abdelsamie A.S.; Bey E.; Gargano E.M.; van Koppen C.J.; Empting M.; Frotscher M.; Towards the evaluation in an animal disease model: Fluorinated 17&#x3B2;-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme. Eur J Med Chem 2015,103,56-68","journal-title":"Eur J Med Chem"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"19914","DOI":"10.3390\/molecules201119661","volume":"20","author":"Noreen M.","year":"2015","unstructured":"Noreen M.; Rasool N.; Gull Y.; Zubair M.; Mahmood T.; Ayub K.; Nasim F.U.; Yaqoob A.; Zia-Ul-Haq M.; de Feo V.; Synthesis, density functional theory (DFT), urease inhibition and antimicrobial activities of 5-aryl thiophenes bearing sulphonylacetamide moieties. Molecules 2015,20(11),19914-19928","journal-title":"Molecules"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14756366.2016.1217851","volume":"31","author":"Debbabi K.F.","year":"2016","unstructured":"Debbabi K.F.; Al-Harbi S.A.; Al-Saidi H.M.; Aljuhani E.H.; Abd El-Gilil S.M.; Bashandy M.S.; Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: Preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase. J Enzyme Inhib Med Chem 2016,31(sup4),7-19","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ejmech.2015.01.036","volume":"92","author":"Ghorab M.M.","year":"2015","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; El-Gazzar M.G.; Zahran S.S.; Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. Eur J Med Chem 2015,92,682-692","journal-title":"Eur J Med Chem"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bmc.2016.11.045","volume":"25","author":"Ivanova J.","year":"2017","unstructured":"Ivanova J.; Balode A.; &#x17D;alubovskis R.; Leitans J.; Kazaks A.; Vullo D.; Tars K.; Supuran C.T.; 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations. Bioorg Med Chem 2017,25(3),857-863","journal-title":"Bioorg Med Chem"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/cmdc.201500594","volume":"11","author":"Toth P.M.","year":"2016","unstructured":"Toth P.M.; Lieber S.; Scheer F.M.; Schumann T.; Schober Y.; Nockher W.A.; Adhikary T.; M&#xFC;ller-Br&#xFC;sselbach S.; M&#xFC;ller R.; Diederich W.E.; Design and synthesis of highly active peroxisome proliferator\u2010activated receptor (PPAR) &#x3B2;\/&#x3B4; inverse agonists with prolonged cellular activity. ChemMedChem 2016,11(5),488-496","journal-title":"ChemMedChem"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1039\/C8MD00474A","volume":"10","author":"Yu Y.","year":"2018","unstructured":"Yu Y.; Tazeem; Xu, Z.; Du, L.; Jin, M.; Dong, C.; Zhou, H.B.; Wu, S. Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus. MedChemComm 2018,10(1),89-100","journal-title":"MedChemComm"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejmech.2018.09.065","volume":"159","author":"Yu Y.","year":"2018","unstructured":"Yu Y.; Tang Q.; Xu Z.; Li S.; Jin M.; Zhao Z.; Dong C.; Wu S.; Zhou H-B.; Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors. Eur J Med Chem 2018,159,206-216","journal-title":"Eur J Med Chem"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1021\/acs.jmedchem.6b00730","volume":"59","author":"Elgaher W.A.","year":"2016","unstructured":"Elgaher W.A.; Sharma K.K.; Haupenthal J.; Saladini F.; Pires M.; Real E.; M&#xE9;ly Y.; Hartmann R.W.; Discovery and structure-based optimization of 2-ureidothiophene-3-carboxylic acids as dual bacterial RNA polymerase and viral reverse transcriptase inhibitors. J Med Chem 2016,59(15),7212-7222","journal-title":"J Med Chem"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/jhet.3849","volume":"57","author":"El\u2010Mekabaty A.","year":"2020","unstructured":"El\u2010Mekabaty A.; Awad H.M.; Convenient synthesis of novel sulfonamide derivatives as promising anticancer agents. J Heterocycl Chem 2020,57(3),1123-1132","journal-title":"J Heterocycl Chem"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejmech.2015.12.017","volume":"110","author":"Gholap S.S.","year":"2016","unstructured":"Gholap S.S.; Pyrrole: An emerging scaffold for construction of valuable therapeutic agents. Eur J Med Chem 2016,110,13-31","journal-title":"Eur J Med Chem"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4314\/bcse.v26i3.12","volume":"26","author":"Idhayadhulla A.","year":"2012","unstructured":"Idhayadhulla A.; Kumar R.S.; Nasser A.A.; Manilal A.; Synthesis and antimicrobial activity of some new pyrrole derivatives. Bull Chem Soc Ethiop 2012,26(3),429-435","journal-title":"Bull Chem Soc Ethiop"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"112783","DOI":"10.1016\/j.ejmech.2020.112783","volume":"208","author":"Li Petri G.","year":"2020","unstructured":"Li Petri G.; Span&#xF2; V.; Spatola R.; Holl R.; Raimondi M.V.; Barraja P.; Montalbano A.; Bioactive pyrrole-based compounds with target selectivity. Eur J Med Chem 2020,208,112783-112783","journal-title":"Eur J Med Chem"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1016\/j.bmcl.2010.08.005","volume":"20","author":"Ghorab M.M.","year":"2010","unstructured":"Ghorab M.M.; Ragab F.A.; Heiba H.I.; Youssef H.A.; El-Gazzar M.G.; Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents. Bioorg Med Chem Lett 2010,20(21),6316-6320","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=239","doi-asserted-by":"crossref","first-page":"01","DOI":"10.18231\/2348-0335.2018.0001","volume":"6","author":"Mohamed M.-A.","year":"2018","unstructured":"Mohamed M.-A.; Mohamed Y.; Eid N.M.; Barsoum F.F.; Synthesis and biological evaluation of some heterocyclic compounds. J Appl Pharm Res 2018,6(2),01-15","journal-title":"J Appl Pharm Res"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2014.09.059","volume":"87","author":"Ghorab M.M.","year":"2014","unstructured":"Ghorab M.M.; Ceruso M.; Alsaid M.S.; Nissan Y.M.; Arafa R.K.; Supuran C.T.; Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling. Eur J Med Chem 2014,87,186-196","journal-title":"Eur J Med Chem"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"112021","DOI":"10.1016\/j.ejmech.2019.112021","volume":"188","author":"Khalil O.M.","year":"2020","unstructured":"Khalil O.M.; Kamal A.M.; Bua S.; El Sayed Teba H.; Nissan Y.M.; Supuran C.T.; Pyrrolo and pyrrolopyrimidine sulfonamides act as cytotoxic agents in hypoxia via inhibition of transmembrane carbonic anhydrases. Eur J Med Chem 2020,188,112021","journal-title":"Eur J Med Chem"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s13738-018-1359-2","volume":"15","author":"Niknam K.","year":"2018","unstructured":"Niknam K.; Bavadi M.; Mojikhalifeh S.; Shahraki O.; A clean synthesis of 2, 5-dihydro-1 H-pyrrole-2-carboxylates under catalyst-free and solvent-free conditions: Cytotoxicity and molecular docking studies. J Iran Chem Soc 2018,15(7),1613-1623","journal-title":"J Iran Chem Soc"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1016\/j.bmc.2015.07.070","volume":"23","author":"Firke S.D.","year":"2015","unstructured":"Firke S.D.; Bari S.B.; Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents. Bioorg Med Chem 2015,23(17),5273-5281","journal-title":"Bioorg Med Chem"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"103658","DOI":"10.1016\/j.bioorg.2020.103658","volume":"97","author":"Balandis B.","year":"2020","unstructured":"Balandis B.; Ivanauskait\u0117 G.; Smirnovien\u0117 J.; Kantminien\u0117 K.; Matulis D.; Mickevi&#x10D;ius V.; Zubrien\u0117 A.; Synthesis and structure-affinity relationship of chlorinated pyrrolidinone-bearing benzenesulfonamides as human carbonic anhydrase inhibitors. Bioorg Chem 2020,97,103658","journal-title":"Bioorg Chem"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00706-016-1847-y","volume":"148","author":"Bavadi M.","year":"2017","unstructured":"Bavadi M.; Niknam K.; Gharibi M.; Synthesis of new dihydropyrrol-2-one derivatives bearing sulfonamide groups and studies their antibacterial activity. Monatsh Chem 2017,148(6),1025-1034","journal-title":"Monatsh Chem"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.bmcl.2015.12.077","volume":"26","author":"Yuan X.","year":"2016","unstructured":"Yuan X.; Lu P.; Xue X.; Qin H.; Fan C.; Wang Y.; Zhang Q.; Discovery of 2-azetidinone and 1H-pyrrole-2,5-dione derivatives containing sulfonamide group at the side chain as potential cholesterol absorption inhibitors. Bioorg Med Chem Lett 2016,26(3),849-853","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ejmech.2014.11.029","volume":"90","author":"Gaikwad D.D.","year":"2015","unstructured":"Gaikwad D.D.; Chapolikar A.D.; Devkate C.G.; Warad K.D.; Tayade A.P.; Pawar R.P.; Domb A.J.; Synthesis of indazole motifs and their medicinal importance: An overview. Eur J Med Chem 2015,90,707-731","journal-title":"Eur J Med Chem"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/13543776.2018.1472240","volume":"28","author":"Denya I.","year":"2018","unstructured":"Denya I.; Malan S.F.; Joubert J.; Indazole derivatives and their therapeutic applications: A patent review (2013-2017). Expert Opin Ther Pat 2018,28(6),441-453","journal-title":"Expert Opin Ther Pat"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"FF01","DOI":"10.7860\/JCDR\/2016\/19338.8465","volume":"10","author":"Cheekavolu C.","year":"2016","unstructured":"Cheekavolu C.; Muniappan M.; In vivo and in vitro anti-inflammatory activity of indazole and its derivatives. J Clin Diagn Res 2016,10(9),FF01-FF06","journal-title":"J Clin Diagn Res"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/cmdc.201800253","volume":"13","author":"Dong J.","year":"2018","unstructured":"Dong J.; Zhang Q.; Wang Z.; Huang G.; Li S.; Recent advances in the development of indazole-based anticancer agents. ChemMedChem 2018,13(15),1490-1507","journal-title":"ChemMedChem"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s00044-013-0835-6","volume":"23","author":"Sapnakumari M.","year":"2014","unstructured":"Sapnakumari M.; Narayana B.; Sarojini B.K.; Madhu L.N.; Synthesis of new indazole derivatives as potential antioxidant agents. Med Chem Res 2014,23(5),2368-2376","journal-title":"Med Chem Res"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"104217","DOI":"10.1016\/j.bioorg.2020.104217","volume":"104","author":"Wan Y.","year":"2020","unstructured":"Wan Y.; Li Y.; Yan C.; Wen J.; Tang Z.; Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors. Bioorg Chem 2020,104,104217","journal-title":"Bioorg Chem"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"239","DOI":"10.25135\/acg.oc.24.17.05.023","volume":"10","author":"Kumar K.","year":"2017","unstructured":"Kumar K.; Vedavathi P.; Kotakadi V.S.; Reddy D.; Raju C.; Design, synthesis, spectral characterization and bioactivity evaluation of new sulfonamide and carbamate derivatives of 5-Nitro-1H-indazole. Org Commun 2017,10(3),239-249","journal-title":"Org Commun"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14756366.2016.1178246","volume":"31","author":"Althaus J.","year":"2016","unstructured":"Althaus J.; Hake T.; Hanekamp W.; Lehr M.; 1-(5- Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A2&#x3B1; and fatty acid amide hydrolase: Bioisosteric replacement of the carboxylic acid moiety. J Enzyme Inhib Med Chem 2016,31(Sup. 1),131-140","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acsmedchemlett.9b00399","volume":"11","author":"Wells C.","year":"2019","unstructured":"Wells C.; Cou&#xF1;ago R.M.; Limas J.C.; Almeida T.L.; Cook J.G.; Drewry D.H.; Elkins J.M.; Gileadi O.; Kapadia N.R.; Lorente-Macias A.; Pickett J.E.; Riemen A.; Ruela-de-Sousa R.R.; Willson T.M.; Zhang C.; Zuercher W.J.; Zutshi R.; Axtman A.D.; SGC-AAK1-1: A chemical probe targeting AAK1 and BMP2K. ACS Med Chem Lett 2019,11(3),340-345","journal-title":"ACS Med Chem Lett"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fchem.2020.00795","volume":"8","author":"Crocetti L.","year":"2020","unstructured":"Crocetti L.; Giovannoni M.P.; Cantini N.; Guerrini G.; Vergelli C.; Schepetkin I.A.; Khlebnikov A.I.; Quinn M.T.; Novel sulfonamide analogs of sivelestat as potent human neutrophil elastase inhibitors. Front Chem 2020,8,795","journal-title":"Front Chem"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2016.08.026","volume":"124","author":"Chang C-F.","year":"2016","unstructured":"Chang C-F.; Lin W-H.; Ke Y-Y.; Lin Y-S.; Wang W-C.; Chen C-H.; Kuo P-C.; Hsu J.T.A.; Uang B-J.; Hsieh H-P.; Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design. Eur J Med Chem 2016,124,186-199","journal-title":"Eur J Med Chem"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jhet.3408","volume":"56","author":"Bassou O.","year":"2019","unstructured":"Bassou O.; Chicha H.; Allam A.; Monticone M.; Gangemi R.; Maric I.; Viale M.; Rakib E.M.; Synthesis and anti\u2010proliferative activity of novel polysubstitued indazole derivatives. J Heterocycl Chem 2019,56(1),343-348","journal-title":"J Heterocycl Chem"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","volume":"163","author":"Gao C.","year":"2019","unstructured":"Gao C.; Chang L.; Xu Z.; Yan X-F.; Ding C.; Zhao F.; Wu X.; Feng L-S.; Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Eur J Med Chem 2019,163,404-412","journal-title":"Eur J Med Chem"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejmech.2019.03.023","volume":"170","author":"Wang S-Q.","year":"2019","unstructured":"Wang S-Q.; Wang Y-F.; Xu Z.; Tetrazole hybrids and their antifungal activities. Eur J Med Chem 2019,170,225-234","journal-title":"Eur J Med Chem"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"104308","DOI":"10.1016\/j.bioorg.2020.104308","volume":"104","author":"Labib M.B.","year":"2020","unstructured":"Labib M.B.; Fayez A.M.; El-Nahass E.S.; Awadallah M.; Halim P.A.; Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE2, TNF-&#x3B1;, IL-6 and histopathological study. Bioorg Chem 2020,104,104308","journal-title":"Bioorg Chem"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/slct.201600286","volume":"1","author":"Suresh A.","year":"2016","unstructured":"Suresh A.; Suresh N.; Misra S.; Kumar M.M.K.; Sekhar K.V.G.C.; Design, synthesis and biological evaluation of new substituted sulfonamide tetrazole derivatives as antitubercular agents. ChemistrySelect 2016,1(8),1705-1710","journal-title":"ChemistrySelect"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1016\/j.bmcl.2011.07.023","volume":"21","author":"Siles R.","year":"2011","unstructured":"Siles R.; Kawasaki Y.; Ross P.; Freire E.; Synthesis and biochemical evaluation of triazole\/tetrazole-containing sulfonamides against thrombin and related serine proteases. Bioorg Med Chem Lett 2011,21(18),5305-5309","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00044-008-9110-7","volume":"18","author":"Y\u0131ld\u0131r\u0131r Y.","year":"2009","unstructured":"Y\u0131ld\u0131r\u0131r Y.; Us M.; Colak N.; &#xD6;zkan H.; Yavuz S.; Disli A.; Ozturk S.; Turker L.; The synthesis and investigation of the antimicrobial activity of some new phenylselanyl-1-(toluene-4-sulfonyl)-1H-tetrazole derivatives. Med Chem Res 2009,18(2),91-97","journal-title":"Med Chem Res"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bmcl.2016.11.028","volume":"27","author":"Esirden \u0130.","year":"2017","unstructured":"Esirden \u0130.; Tan&#xE7; M.; Supuran C.T.; Kaya M.; Microwave assisted synthesis of novel tetrazole\/sulfonamide derivatives based on octahydroacridine, xanthene and chromene skeletons as inhibitors of the carbonic anhydrases isoforms I, II, IV and VII. Bioorg Med Chem Lett 2017,27(1),86-89","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.molstruc.2016.04.071","volume":"1119","author":"Jawabrah Al-Hourani B.","year":"2016","unstructured":"Jawabrah Al-Hourani B.; El-Barghouthi M.I.; McDonald R.; Al-Awaida W.; Sharma S.K.; Wuest F.; Synthesis and crystal structure of N-[(dimethylamino)methylidene]-4-[1-(4-nitrophenyl)-1H-tetrazol-5-yl]-benzenesulfonamide: Molecular docking and bioassay studies as cyclooxygenase-2 inhibitor. J Mol Struct 2016,1119,220-226","journal-title":"J Mol Struct"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molstruc.2019.05.065","volume":"1195","author":"Akram T.","year":"2019","unstructured":"Akram T.; Abbasi M.A.; Mahmood A.; de Lima E.B.; Perveen F.; Ashraf M.; Ahmad I.; Goumri-Said S.; Synthesis, molecular structure, spectroscopic properties and biological evaluation of 4-substituted-N-(1H-tetrazol-5-yl) benzenesulfonamides: Combined experimental, DFT and docking study. J Mol Struct 2019,1195,119-130","journal-title":"J Mol Struct"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.bmcl.2016.08.034","volume":"26","author":"Jawabrah Al-Hourani B.","year":"2016","unstructured":"Jawabrah Al-Hourani B.; Al-Awaida W.; Matalka K.Z.; El-Barghouthi M.I.; Alsoubani F.; Wuest F.; Structure-activity relationship of novel series of 1,5-disubstituted tetrazoles as cyclooxygenase-2 inhibitors: Design, synthesis, bioassay screening and molecular docking studies. Bioorg Med Chem Lett 2016,26(19),4757-4762","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.bioorg.2018.02.010","volume":"77","author":"Lin S-Y.","year":"2018","unstructured":"Lin S-Y.; Yeh T-K.; Song J-S.; Hung M-S.; Cheng M-F.; Liao F-Y.; Li A-S.; Cheng S-Y.; Lin L-M.; Chiu C-H.; Wu M.H.; Lin Y.J.; Hsiao W.; Sun M.; Wang Y.H.; Huang C.H.; Tang Y.C.; Chang H.H.; Huang Z.T.; Chao Y.S.; Shih C.; Pan S.L.; Wu S.Y.; Kuo C.C.; Ueng S.H.; 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy. Bioorg Chem 2018,77,600-607","journal-title":"Bioorg Chem"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/14756366.2017.1326110","volume":"32","author":"Lamie P.F.","year":"2017","unstructured":"Lamie P.F.; Philoppes J.N.; Azouz A.A.; Safwat N.M.; Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: Design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study. J Enzyme Inhib Med Chem 2017,32(1),805-820","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"103262","DOI":"10.1016\/j.bioorg.2019.103262","volume":"92","author":"Okasha R.M.","year":"2019","unstructured":"Okasha R.M.; Alsehli M.; Ihmaid S.; Althagfan S.S.; El-Gaby M.S.A.; Ahmed H.E.A.; Afifi T.H.; First example of Azo-Sulfa conjugated chromene moieties: Synthesis, characterization, antimicrobial assessment, docking simulation as potent class I histone deacetylase inhibitors and antitumor agents. Bioorg Chem 2019,92,103262","journal-title":"Bioorg Chem"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jphotobiol.2016.09.032","volume":"164","author":"Nawaz M.","year":"2016","unstructured":"Nawaz M.; Abbasi M.W.; Hisaindee S.; Synthesis, characterization, anti-bacterial, anti-fungal and nematicidal activities of 2-amino-3-cyanochromenes. J Photochem Photobiol B 2016,164,160-163","journal-title":"J Photochem Photobiol B"},{"key":"ref=273","first-page":"1054","volume":"9","author":"Kumar M.","year":"2020","unstructured":"Kumar M.; Jeyachandran V.; Antioxidant actions of amino chromene products with alkyl tail: Synthesis and characterisation. Int J Mod Agric 2020,9(4),1054-1058","journal-title":"Int J Mod Agric"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1039\/c3ra47252c","volume":"4","author":"Qiang D.","year":"2014","unstructured":"Qiang D.; Shi J.B.; Song B.A.; Liu X.H.; Novel 2 H-chromen derivatives: Design, synthesis and anticancer activity. RSC Advances 2014,4(11),5607-5617","journal-title":"RSC Advances"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1021\/acs.jmedchem.6b01720","volume":"60","author":"Reis J.","year":"2017","unstructured":"Reis J.; Gaspar A.; Milhazes N.; Borges F.; Chromone as a privileged scaffold in drug discovery: Recent advances. J Med Chem 2017,60(19),7941-7957","journal-title":"J Med Chem"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.fitote.2019.04.012","volume":"135","author":"Duan Y.D.","year":"2019","unstructured":"Duan Y.D.; Jiang Y.Y.; Guo F.X.; Chen L.X.; Xu L.L.; Zhang W.; Liu B.; The antitumor activity of naturally occurring chromones: A review. Fitoterapia 2019,135,114-129","journal-title":"Fitoterapia"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bmc.2015.01.042","volume":"23","author":"Liu Q.","year":"2015","unstructured":"Liu Q.; Qiang X.; Li Y.; Sang Z.; Li Y.; Tan Z.; Deng Y.; Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 2015,23(5),911-923","journal-title":"Bioorg Med Chem"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1002\/jhet.2868","volume":"54","author":"Dofe V.S.","year":"2017","unstructured":"Dofe V.S.; Sarkate A.P.; Lokwani D.K.; Shinde D.B.; Kathwate S.H.; Gill C.H.; Novel o\u2010alkylated chromones as antimicrobial agents: Ultrasound mediated synthesis, molecular docking and ADME prediction. J Heterocycl Chem 2017,54(5),2678-2685","journal-title":"J Heterocycl Chem"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","volume":"124","author":"Ghorab M.M.","year":"2016","unstructured":"Ghorab M.M.; Alsaid M.S.; Al-Ansary G.H.; Abdel-Latif G.A.; Abou El Ella D.A.; Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers. Eur J Med Chem 2016,124,946-958","journal-title":"Eur J Med Chem"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1573406411309040015","volume":"9","author":"Ul-Haq Z.","year":"2013","unstructured":"Ul-Haq Z.; Usmani S.; Mahmood U.; Al-Rashida M.; Abbas G.; In-silico analysis of chromone containing sulfonamide derivatives as human carbonic anhydrase inhibitors. Med Chem 2013,9(4),608-616","journal-title":"Med Chem"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3109\/14756366.2011.614607","volume":"27","author":"Ekinci D.","year":"2012","unstructured":"Ekinci D.; Al-Rashida M.; Abbas G.; &#x15E;ent&#xFC;rk M.; Supuran C.T.; Chromone containing sulfonamides as potent carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012,27(5),744-747","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jhet.2576","volume":"54","author":"Gouda M.A.","year":"2017","unstructured":"Gouda M.A.; Synthesis and antioxidant evaluation of some novel thiophene, pyrazole, chromene, pyrazolotriazine derivatives bearing sulfonamide moiety. J Heterocycl Chem 2017,54(1),268-277","journal-title":"J Heterocycl Chem"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bioorg.2017.10.001","volume":"75","author":"Abid S.M.A.","year":"2017","unstructured":"Abid S.M.A.; Younus H.A.; Al-Rashida M.; Arshad Z.; Maryum T.; Gilani M.A.; Alharthi A.I.; Iqbal J.; Sulfonyl hydrazones derived from 3-formylchromone as non-selective inhibitors of MAO-A and MAO-B: Synthesis, molecular modelling and in-silico ADME evaluation. Bioorg Chem 2017,75,291-302","journal-title":"Bioorg Chem"},{"key":"ref=284","first-page":"4461","volume":"8","author":"Kaur L.","year":"2017","unstructured":"Kaur L.; Singh M.P.; Synthesis and pharmacological evaluation of substituted n-(3-formyl-4-oxo-4h-chromen-2-yl)-n-phenylbenzenesulfonamide and its derivatives. Int J Pharm Sci Res 2017,8(10),4461-4472","journal-title":"Int J Pharm Sci Res"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","volume":"96","author":"Awadallah F.M.","year":"2015","unstructured":"Awadallah F.M.; El-Waei T.A.; Hanna M.M.; Abbas S.E.; Ceruso M.; Oz B.E.; Guler O.O.; Supuran C.T.; Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives. Eur J Med Chem 2015,96,425-435","journal-title":"Eur J Med Chem"},{"key":"ref=286","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.26452\/ijrps.v10i4.1596","volume":"10","author":"Chopra A.","year":"2019","unstructured":"Chopra A.; Singh L.; Kapoor V.; Dhingra R.; Passi N.; Design, synthesis, molecular docking and evaluation of antimicrobial activity of 4-amino-n-[(4-oxo-2-(phenylamino)-4h-chromen-3-yl) methy-lene]benzenesulfonamide and their derivatives. Int J Pharm Sci Res 2019,10,3073-3084","journal-title":"Int J Pharm Sci Res"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"112946","DOI":"10.1016\/j.ejmech.2020.112946","volume":"209","author":"He Z-X.","year":"2021","unstructured":"He Z-X.; Gong Y-P.; Zhang X.; Ma L-Y.; Zhao W.; Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules. Eur J Med Chem 2021,209,112946","journal-title":"Eur J Med Chem"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"47","DOI":"10.33945\/SAMI\/JCR.2019.1.4765","volume":"1","author":"Asif M.","year":"2019","unstructured":"Asif M.; Calcium sensitizing and phosphodiesterase-III inhibitory activity of pyridazine compounds: A review. J Chem Rev 2019,1(1),47-65","journal-title":"J Chem Rev"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"103497","DOI":"10.1016\/j.bioorg.2019.103497","volume":"95","author":"Ahmed E.M.","year":"2020","unstructured":"Ahmed E.M.; Hassan M.S.A.; El-Malah A.A.; Kassab A.E.; New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Bioorg Chem 2020,95,103497","journal-title":"Bioorg Chem"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"e2000100","DOI":"10.1002\/cbdv.202000100","volume":"17","author":"Mustafa M.","year":"2020","unstructured":"Mustafa M.; Mostafa Y.A.; Antimicrobial pyridazines: Synthesis, characterization, cytotoxicity, substrate promiscuity, and molecular docking. Chem Biodivers 2020,17(6),e2000100","journal-title":"Chem Biodivers"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bmc.2017.11.051","volume":"26","author":"Murineddu G.","year":"2018","unstructured":"Murineddu G.; Deligia F.; Ragusa G.; Garc&#xED;a-Toscano L.; G&#xF3;mez-Ca&#xF1;as M.; Asproni B.; Satta V.; Cichero E.; Pazos R.; Fossa P.; Loriga G.; Fern&#xE1;ndez-Ruiz J.; Pinna G.A.; Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists. Bioorg Med Chem 2018,26(1),295-307","journal-title":"Bioorg Med Chem"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00044-013-0605-5","volume":"23","author":"Deeb A.","year":"2014","unstructured":"Deeb A.; El-Eraky W.; El-Awdan S.; Mahgoub S.; Pyridazine and its related compounds. Part 34. Hypoglycemic and hypolipidemic activity of some novel condensed pyridazine sulfonamides. Med Chem Res 2014,23(1),34-41","journal-title":"Med Chem Res"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.bmcl.2015.12.016","volume":"26","author":"Yaseen R.","year":"2016","unstructured":"Yaseen R.; Ekinci D.; Senturk M.; Hameed A.D.; Ovais S.; Rathore P.; Samim M.; Javed K.; Supuran C.T.; Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2016,26(4),1337-1341","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"104057","DOI":"10.1016\/j.bioorg.2020.104057","volume":"102","author":"Hamad A.","year":"2020","unstructured":"Hamad A.; Khan M.A.; Rahman K.M.; Ahmad I.; Ul-Haq Z.; Khan S.; Shafiq Z.; Development of sulfonamide-based Schiff bases targeting urease inhibition: Synthesis, characterization, inhibitory activity assessment, molecular docking and ADME studies. Bioorg Chem 2020,102,104057","journal-title":"Bioorg Chem"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5155\/eurjchem.6.1.88-92.1166","volume":"6","author":"Deeb A.A.","year":"2015","unstructured":"Deeb A.A.; El-Eraky W.I.; Mohamed S.M.; Pyridazine and its related compounds. Part 35 [1]: Synthesis, characterization and antimicrobial activity of some novel pyridazine and triazolopyridazine containing sulfonamides. Eur J Chem 2015,6(1),88-92","journal-title":"Eur J Chem"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1248\/cpb.c16-00532","volume":"65","author":"Elmeligie S.","year":"2017","unstructured":"Elmeligie S.; Ahmed E.M.; Abuel-Maaty S.M.; Zaitone S.A-B.; Mikhail D.S.; Design and synthesis of pyridazine containing compounds with promising anticancer activity. Chem Pharm Bull (Tokyo) 2017,65(3),236-247","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejmech.2019.02.044","volume":"168","author":"Krasavin M.","year":"2019","unstructured":"Krasavin M.; Shetnev A.; Baykov S.; Kalinin S.; Nocentini A.; Sharoyko V.; Poli G.; Tuccinardi T.; Korsakov M.; Tennikova T.B.; Supuran C.T.; Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines. Eur J Med Chem 2019,168,301-314","journal-title":"Eur J Med Chem"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.14233\/ajchem.2015.19123","volume":"27","author":"Altalbawy F.","year":"2015","unstructured":"Altalbawy F.; Synthesis, in vitro Antimicrobial and anticancer evaluation of some new pyridazines and polyfunctionally substituted heterocyclic compounds. Asian J Chem 2015,27(12),4361-4368","journal-title":"Asian J Chem"},{"key":"ref=299","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5497\/wjp.v6.i2.11","volume":"6","author":"Irfan A.","year":"2017","unstructured":"Irfan A.; Tahir O.A.; Umer M.; Ahmad S.; Kousar H.; A review on biological studies of Quinoxaline derivatives. World J Pharm Sci 2017,6(2),11-30","journal-title":"World J Pharm Sci"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejmech.2018.11.059","volume":"163","author":"Montana M.","year":"2019","unstructured":"Montana M.; Mathias F.; Terme T.; Vanelle P.; Antitumoral activity of quinoxaline derivatives: A systematic review. Eur J Med Chem 2019,163,136-147","journal-title":"Eur J Med Chem"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejmech.2016.04.019","volume":"117","author":"Patel S.B.","year":"2016","unstructured":"Patel S.B.; Patel B.D.; Pannecouque C.; Bhatt H.G.; Design, synthesis and anti-HIV activity of novel quinoxaline derivatives. Eur J Med Chem 2016,117,230-240","journal-title":"Eur J Med Chem"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bmc.2018.11.021","volume":"27","author":"Kaushal T.","year":"2019","unstructured":"Kaushal T.; Srivastava G.; Sharma A.; Singh Negi A.; An insight into medicinal chemistry of anticancer quinoxalines. Bioorg Med Chem 2019,27(1),16-35","journal-title":"Bioorg Med Chem"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"19805","DOI":"10.3390\/molecules201119655","volume":"20","author":"Al-Marhabi A.R.","year":"2015","unstructured":"Al-Marhabi A.R.; Abbas H-A.S.; Ammar Y.A.; Synthesis, characterization and biological evaluation of some quinoxaline derivatives: A promising and potent new class of antitumor and antimicrobial agents. Molecules 2015,20(11),19805-19822","journal-title":"Molecules"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bioorg.2014.05.010","volume":"56","author":"Shahin M.I.","year":"2014","unstructured":"Shahin M.I.; Abou El Ella D.A.; Ismail N.S.M.; Abouzid K.A.M.; Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold. Bioorg Chem 2014,56,16-26","journal-title":"Bioorg Chem"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/molecules24061175","volume":"24","author":"El Newahie A.M.S.","year":"2019","unstructured":"El Newahie A.M.S.; Nissan Y.M.; Ismail N.S.M.; Abou El Ella D.A.; Khojah S.M.; Abouzid K.A.M.; Design and synthesis of new quinoxaline derivatives as anticancer agents and apoptotic inducers. Molecules 2019,24(6),1175","journal-title":"Molecules"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejmech.2013.04.028","volume":"65","author":"Ingle R.","year":"2013","unstructured":"Ingle R.; Marathe R.; Magar D.; Patel H.M.; Surana S.J.; Sulphonamido-quinoxalines: Search for anticancer agent. Eur J Med Chem 2013,65,168-186","journal-title":"Eur J Med Chem"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1007\/s11164-017-2895-6","volume":"43","author":"Alavi S.","year":"2017","unstructured":"Alavi S.; Mosslemin M.H.; Mohebat R.; Massah A.R.; Green synthesis of novel quinoxaline sulfonamides with antibacterial activity. Res Chem Intermed 2017,43(8),4549-4559","journal-title":"Res Chem Intermed"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.bmc.2019.03.015","volume":"27","author":"Ji Y.","year":"2019","unstructured":"Ji Y.; Chen X.; Chen H.; Zhang X.; Fan Z.; Xie L.; Ma B.; Zhu C.; Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors. Bioorg Med Chem 2019,27(8),1658-1669","journal-title":"Bioorg Med Chem"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00436-018-5834-6","volume":"117","author":"Bhoj P.S.","year":"2018","unstructured":"Bhoj P.S.; Ingle R.G.; Goswami K.; Jena L.; Wadher S.; Apoptotic impact on Brugia malayi by sulphonamido-quinoxaline: Search for a novel therapeutic rationale. Parasitol Res 2018,117(5),1559-1572","journal-title":"Parasitol Res"},{"key":"ref=310","first-page":"S47","volume":"11","author":"Bhati S.","year":"2017","unstructured":"Bhati S.; In silico evaluation of inhibitory potential of sulfonamide derivatives against diadenosine tetraphosphate hydrolase as antimalarial agents. Asian J Pharm 2017,11,S47","journal-title":"Asian J Pharm"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"15776","DOI":"10.1039\/C7RA01026E","volume":"7","author":"Gensicka-Kowalewska M.","year":"2017","unstructured":"Gensicka-Kowalewska M.; Cholewi\u0144ski G.; Dzierzbicka K.; Recent developments in the synthesis and biological activity of acridine\/acridone analogues. RSC Advances 2017,7(26),15776-15804","journal-title":"RSC Advances"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1517\/13543776.2014.902052","volume":"24","author":"Zhang B.","year":"2014","unstructured":"Zhang B.; Li X.; Li B.; Gao C.; Jiang Y.; Acridine and its derivatives: A patent review (2009 - 2013). Expert Opin Ther Pat 2014,24(6),647-664","journal-title":"Expert Opin Ther Pat"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1533317515603115","volume":"31","author":"Munawar R.","year":"2016","unstructured":"Munawar R.; Mushtaq N.; Arif S.; Ahmed A.; Akhtar S.; Ansari S.; Meer S.; Saify Z.S.; Arif M.; Synthesis of 9-aminoacridine derivatives as anti-Alzheimer agents. Am J Alzheimers Dis Other Demen 2016,31(3),263-269","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s00044-014-1268-6","volume":"24","author":"Arya S.","year":"2015","unstructured":"Arya S.; Kumar A.; Kumar N.; Roy P.; Sondhi S.M.; Synthesis and anticancer activity evaluation of some acridine derivatives. Med Chem Res 2015,24(5),1942-1951","journal-title":"Med Chem Res"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11094-015-1181-4","volume":"48","author":"Kaya M.","year":"2015","unstructured":"Kaya M.; Y\u0131ld\u0131r\u0131r Y.; &#xC7;elik G.Y.; Synthesis, characterization, and in vitro antimicrobial and antifungal activity of novel acridines. Pharm Chem J 2015,48(11),722-726","journal-title":"Pharm Chem J"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.1016\/j.bmc.2015.09.022","volume":"23","author":"Esirden \u0130.","year":"2015","unstructured":"Esirden \u0130.; Ulus R.; Aday B.; Tan&#xE7; M.; Supuran C.T.; Kaya M.; Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem 2015,23(20),6573-6580","journal-title":"Bioorg Med Chem"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00706-013-1145-x","volume":"145","author":"Ye&#x15F;ilda&#x11F; \u0130.","year":"2014","unstructured":"Ye&#x15F;ilda&#x11F; \u0130.; Ulus R.; Ba&#x15F;ar E.; Aslan M.; Kaya M.; B&#xFC;lb&#xFC;l M.; Facile, highly efficient, and clean one-pot synthesis of acridine sulfonamide derivatives at room temperature and their inhibition of human carbonic anhydrase isoenzymes. Monatsh Chem 2014,145(6),1027-1034","journal-title":"Monatsh Chem"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1016\/j.bmc.2013.07.014","volume":"21","author":"Ulus R.","year":"2013","unstructured":"Ulus R.; Ye&#x15F;ilda&#x11F; I.; Tan&#xE7; M.; B&#xFC;lb&#xFC;l M.; Kaya M.; Supuran C.T.; Synthesis of novel acridine and bis acridine sulfonamides with effective inhibitory activity against the cytosolic carbonic anhydrase isoforms II and VII. Bioorg Med Chem 2013,21(18),5799-5805","journal-title":"Bioorg Med Chem"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00044-017-2088-2","volume":"27","author":"Ulus R.","year":"2018","unstructured":"Ulus R.; Esirden \u0130.; Aday B.; Turgut G.&#xC7;.; &#x15E;en A.; Kaya M.; Synthesis of novel acridine-sulfonamide hybrid compounds as acetylcholinesterase inhibitor for the treatment of Alzheimer\u2019s disease. Med Chem Res 2018,27(2),634-641","journal-title":"Med Chem Res"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14756366.2016.1187605","volume":"31","author":"Ulus R.","year":"2016","unstructured":"Ulus R.; Kaya M.; Demir D.; Tunca E.; B&#xFC;lb&#xFC;l M.; Three-component synthesis and carbonic anhydrase inhibitory properties of novel octahydroacridines incorporating sulfaguanidine scaffold. J Enzyme Inhib Med Chem 2016,31(sup2),63-69","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"330","DOI":"10.21608\/ejchem.2018.2934.1242","volume":"61","author":"Soliman A.","year":"2018","unstructured":"Soliman A.; Kamel M.; Eweas A.; Wietrzyk J.; Milczarek M.; The antiproliferative activity and molecular docking studies of some sulfonamides against cancer cell lines compared to normal cells. Egypt J Chem 2018,61(3),330-340","journal-title":"Egypt J Chem"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/14756366.2017.1302441","volume":"32","author":"Bragagni M.","year":"2017","unstructured":"Bragagni M.; Carta F.; Osman S.M.; AlOthman Z.; Supuran C.T.; Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action. J Enzyme Inhib Med Chem 2017,32(1),701-706","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=323","first-page":"2526","volume":"11","author":"Aswathy J.","year":"2019","unstructured":"Aswathy J.; A concise review on phthlazine derivatives and its biological activities. J Pharm Sci Res 2019,11(7),2526-2532","journal-title":"J Pharm Sci Res"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1016\/j.bmc.2019.07.050","volume":"27","author":"Sangshetti J.","year":"2019","unstructured":"Sangshetti J.; Pathan S.K.; Patil R.; Akber Ansari S.; Chhajed S.; Arote R.; Shinde D.B.; Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review. Bioorg Med Chem 2019,27(18),3979-3997","journal-title":"Bioorg Med Chem"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"e1800387","DOI":"10.1002\/ardp.201800387","volume":"352","author":"El-Helby A.A.","year":"2019","unstructured":"El-Helby A.A.; Ayyad R.R.A.; Zayed M.F.; Abulkhair H.S.; Elkady H.; El-Adl K.; Design, synthesis, in silico ADMET profile and GABA-A docking of novel phthalazines as potent anticonvulsants. Arch Pharm (Weinheim) 2019,352(5),e1800387","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=326","first-page":"1000191","volume":"5","author":"El-Hashash M.A.","year":"2014","unstructured":"El-Hashash M.A.; Guirguis D.B.; Abdel-Wahed N.A.; Kadhim M.A.; Synthesis of novel series of phthalazine derivatives with antibacterial and antifungal evaluation. J Chem Eng Process Technol 2014,5(4),1000191-1000196","journal-title":"J Chem Eng Process Technol"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ardp.201500336","volume":"349","author":"Hameed A.D.","year":"2016","unstructured":"Hameed A.D.; Ovais S.; Yaseen R.; Rathore P.; Samim M.; Singh S.; Sharma K.; Akhtar M.; Javed K.; Synthesis and biological evaluation of new phthalazinone derivatives as anti\u2010inflammatory and anti\u2010proliferative agents. Arch Pharm (Weinheim) 2016,349(2),150-159","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s12039-017-1337-8","volume":"129","author":"Abbasi M.","year":"2017","unstructured":"Abbasi M.; Nazifi S.; Nazifi Z.; Massah A.R.; Synthesis, characterization and in vitro antibacterial activity of novel phthalazine sulfonamide derivatives. J Chem Sci 2017,129(8),1257-1266","journal-title":"J Chem Sci"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"103004","DOI":"10.1016\/j.bioorg.2019.103004","volume":"89","author":"T&#xFC;rke&#x15F; C.","year":"2019","unstructured":"T&#xFC;rke&#x15F; C.; Arslan M.; Demir Y.; &#xC7;o&#xE7;aj L.; Rifati Nixha A.; Beydemir &#x15E;.; Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem 2019,89,103004","journal-title":"Bioorg Chem"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/aps.2016.4","volume":"37","author":"Ran J-H.","year":"2016","unstructured":"Ran J-H.; Li M.; Tou W-I.; Lei T-L.; Zhou H.; Chen C.Y-C.; Yang B-X.; Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding model. Acta Pharmacol Sin 2016,37(7),973-983","journal-title":"Acta Pharmacol Sin"},{"key":"ref=331","first-page":"75","volume":"8","author":"Singh A.","year":"2016","unstructured":"Singh A.; Kaur N.; Sharma S.; Bedi P.; Recent progress in biologically active xanthones. J Chem Pharm Res 2016,8,75-131","journal-title":"J Chem Pharm Res"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11696-020-01320-0","volume":"75","author":"Ramakrishnan S.","year":"2021","unstructured":"Ramakrishnan S.; Paramewaran S.; Nasir N.M.; Synthetic approaches to biologically active xanthones: An update. Chem Pap 2021,75(2),455-470","journal-title":"Chem Pap"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ejmech.2018.07.073","volume":"157","author":"Santos C.M.M.","year":"2018","unstructured":"Santos C.M.M.; Freitas M.; Fernandes E.; A comprehensive review on xanthone derivatives as &#x3B1;-glucosidase inhibitors. Eur J Med Chem 2018,157,1460-1479","journal-title":"Eur J Med Chem"},{"key":"ref=334","first-page":"183","volume":"8","author":"Alam S.","year":"2014","unstructured":"Alam S.; Khan F.; QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II&#x3B1;. Drug Des Devel Ther 2014,8,183-195","journal-title":"Drug Des Devel Ther"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"126927","DOI":"10.1016\/j.bmcl.2019.126927","volume":"30","author":"Kou X.","year":"2020","unstructured":"Kou X.; Song L.; Wang Y.; Yu Q.; Ju H.; Yang A.; Shen R.; Design, synthesis and anti-Alzheimer\u2019s disease activity study of xanthone derivatives based on multi-target strategy. Bioorg Med Chem Lett 2020,30(4),126927","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3184\/174751915X14373971129805","volume":"39","author":"Malekpoor M.","year":"2015","unstructured":"Malekpoor M.; Gharaghani S.; Sharifzadeh A.; Mirsattari S.N.; Massah A.R.; Synthesis and antibacterial evaluation of novel Xanthone Sulfonamides. J Chem Res 2015,39(8),433-437","journal-title":"J Chem Res"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/molecules23061396","volume":"23","author":"Wang P.","year":"2018","unstructured":"Wang P.; Jiang L.; Cao Y.; Ye D.; Zhou L.; The design and synthesis of N-xanthone benzenesulfonamides as novel phosphoglycerate mutase 1 (PGAM1) inhibitors. Molecules 2018,23(6),1396","journal-title":"Molecules"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cbdd.12419","volume":"85","author":"Li X.","year":"2015","unstructured":"Li X.; Zou Y.; Zhao Q.; Yang Y.; Wu M.; Huang T.; Hu H.; Wu Q.; Synthesis, biological evaluation, and molecular docking studies of Xanthone Sulfonamides as ACAT inhibitors. Chem Biol Drug Des 2015,85(3),394-403","journal-title":"Chem Biol Drug Des"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220722143547","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207003\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220722143547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:56:00Z","timestamp":1693655760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207003\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":338,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220722143547","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}